Document And Entity Information (USD $) In Millions, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Feb. 21, 2012	Jun. 30, 2011
Document And Entity Information [Abstract]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2011
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	FY
Entity Filer Category	Large Accelerated Filer
Entity Registrant Name	INTEGRA LIFESCIENCES HOLDINGS CORP
Entity Central Index Key	0000917520
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Public Float			$ 956.2
Entity Common Stock, Shares Outstanding		26,879,851

Condensed Consolidated Statements Of Operations (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Condensed Consolidated Statements Of Operations [Abstract]
Total revenue, net	$ 780,078	$ 732,068	$ 682,487
Costs and Expenses:
Cost of product revenues	299,150	268,188	244,918
Research and development	51,451	48,114	44,280
Selling, general and administrative	358,132	305,055	281,102
Intangible asset amortization	16,433	12,017	14,363
Total costs and expenses	725,166	633,374	584,663
Operating income	54,912	98,694	97,824
Interest income	465	225	631
Interest expense	(27,640)	(18,356)	(23,227)
Other income (expense), net	757	1,551	(2,076)
Income before income taxes	28,494	82,114	73,152
Provision for income taxes	505	16,445	22,197
Net income	$ 27,989	$ 65,669	$ 50,955
Basic net income per common share	$ 0.97	$ 2.21	$ 1.75
Diluted net income per common share	$ 0.95	$ 2.17	$ 1.74
Weighted average common shares outstanding (See Note 11):
Basic	28,952	29,548	29,038
Diluted	29,495	30,149	29,292

Condensed Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Current Assets:
Cash and cash equivalents	$ 100,808	$ 128,763
Trade accounts receivable, net of allowances of $6,978 and $7,322	118,129	106,005
Inventories, net	171,261	146,928
Deferred tax assets	36,155	35,284
Prepaid expenses and other current assets	25,904	27,869
Total current assets	452,257	444,849
Property, plant and equipment, net	131,383	99,456
Intangible assets, net	237,122	194,904
Goodwill	292,980	261,928
Deferred tax assets	17,239	7,894
Other assets	13,128	10,102
Total assets	1,144,109	1,019,133
Current Liabilities:
Borrowings under senior credit facility		108,438
Accounts payable, trade	27,656	27,783
Deferred revenue	4,543	4,444
Accrued compensation	28,010	27,562
Accrued expenses and other current liabilities	41,659	33,630
Total current liabilities	101,868	201,857
Long-term borrowings under senior credit facility	179,688	139,688
Long-term convertible securities	352,576	155,154
Deferred tax liabilities	5,726	10,645
Other liabilities	11,613	11,826
Total liabilities	651,471	519,170
Commitments and contingencies
Stockholders' Equity:
Preferred Stock; no par value; 15,000 authorized shares; none outstanding
Common stock; $.01 par value; 60,000 authorized shares; 35,734 and 35,527 issued	357	355
Additional paid-in capital	607,676	552,231
Treasury stock, at cost; 8,903 and 6,994 shares	(367,121)	(283,658)
Accumulated other comprehensive income (loss):
Foreign currency translation adjustment	(6,494)	(870)
Pension liability adjustment, net of tax	(131)	(771)
Unrealized (loss) gain on derivatives, net of tax	(2,468)	(154)
Retained earnings	260,819	232,830
Total stockholders' equity	492,638	499,963
Total liabilities and stockholders' equity	$ 1,144,109	$ 1,019,133

Condensed Consolidated Balance Sheets (Parenthetical) (USD $) In Thousands, except Share data, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Condensed Consolidated Balance Sheets [Abstract]
Trade accounts receivable, allowances	$ 6,978	$ 7,322
Preferred Stock, par value	$ 0	$ 0
Preferred Stock, authorized shares	15,000,000	15,000,000
Preferred Stock, outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	60,000,000	60,000,000
Common stock, shares issued	35,734,000	35,527,000
Treasury stock, shares	8,903,000	6,994,000

- Definition

Issuance value per share of no-par value, nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share.

+ References+ Details

Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
OPERATING ACTIVITIES:
Net income	$ 27,989	$ 65,669	$ 50,955
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	50,172	39,172	39,688
In-process research and development			277
Deferred income tax provision (benefit)	1,156	4,128	548
Share-based compensation	26,805	17,209	15,580
Amortization of debt issuance costs	3,387	1,490	2,400
Non-cash interest expense	10,591	7,125	9,899
Payment of accreted interest		(6,599)	(5,391)
Gain on convertible note repurchases			(480)
Excess tax benefits from stock-based compensation arrangements	(848)	(3,580)	(20)
Other, net	164	(3)
Changes in assets and liabilities, net of business acquisitions:
Accounts receivable	(1,878)	(3,783)	9,808
Inventories	1,702	(7,374)	9,405
Prepaid expenses and other current assets	(395)	(6,452)	7,029
Other non-current assets	375	(179)	411
Accounts payable, accrued expenses and other current liabilities	(11,842)	6,736	4,550
Deferred revenue	104	(457)	(289)
Other liabilities	(3,154)	(7,531)	(1,135)
Net cash provided by operating activities	104,328	105,571	143,235
INVESTING ACTIVITIES:
Cash used in business acquisitions, net of cash acquired	(151,951)	(5,178)	(60,783)
Purchases of property and equipment	(38,425)	(37,138)	(25,238)
Purchases of intangible assets			(2,331)
Net cash used in investing activities	(190,376)	(42,316)	(88,352)
FINANCING ACTIVITIES:
Borrowings under senior credit facility	145,000	105,000
Repayments under senior credit facility	(213,437)	(16,875)	(100,000)
Proceeds from liability component of convertible notes	186,830
Proceeds from equity component of convertible notes	43,170
Proceeds from the sale of stock purchase warrants	28,451
Purchase of option hedge on convertible notes	(42,895)
Repurchase of liability component of convertible notes		(71,351)	(78,005)
Debt issuance costs	(8,064)	(6,796)
Purchases of treasury stock	(83,463)	(31,278)
Proceeds from exercised stock options	3,697	16,146	6,643
Excess tax benefits from stock-based compensation arrangements	848	3,580	20
Net cash (used in) provided by financing activities	60,137	(1,574)	(171,342)
Effect of exchange rate changes on cash and cash equivalents	(2,044)	(4,809)	4,804
Net increase (decrease) in cash and cash equivalents	(27,955)	56,872	(111,655)
Cash and cash equivalents at beginning of period	128,763	71,891	183,546
Cash and cash equivalents at end of period	$ 100,808	$ 128,763	$ 71,891

Condensed Consolidated Statements Of Changes In Stockholders' Equity (USD $) In Thousands	Common Stock [Member]	Treasury Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2008	$ 341	$ (252,380)	$ 502,787	$ 5,355	$ 116,206	$ 372,309
Balance, shares at Dec. 31, 2008	34,134	(6,136)
Net income					50,955	50,955
Foreign currency translation				3,432		3,432
Minimum pension liability adjustment, net of tax				99		99
Unrealized gain (loss) on derivatives, net of tax				19		19
Total comprehensive income						54,505
Issuance of common stock through employee benefit plans, value	6		3,145			3,151
Issuance of common stock through employee benefit plans, shares	606
Share-based compensation			14,938			14,938
Repurchase of equity component of convertible debt			(18)			(18)
Balance at Dec. 31, 2009	347	(252,380)	520,852	8,905	167,161	444,885
Balance, shares at Dec. 31, 2009	34,740	(6,136)
Net income					65,669	65,669
Foreign currency translation				(10,616)		(10,616)
Minimum pension liability adjustment, net of tax				89		89
Unrealized gain (loss) on derivatives, net of tax				(173)		(173)
Total comprehensive income						54,969
Issuance of common stock through employee benefit plans, value	8		10,610			10,618
Issuance of common stock through employee benefit plans, shares	787
Share-based compensation			20,769			20,769
Repurchase of common stock		(31,278)				(31,278)
Repurchase of common stock, shares		(858)
Balance at Dec. 31, 2010	355	(283,658)	552,231	(1,795)	232,830	499,963
Balance, shares at Dec. 31, 2010	35,527	(6,994)
Net income					27,989	27,989
Foreign currency translation				(5,624)		(5,624)
Minimum pension liability adjustment, net of tax				640		640
Unrealized gain (loss) on derivatives, net of tax				(2,314)		(2,314)
Total comprehensive income						20,691
Issuance of common stock through employee benefit plans, value	2		374			376
Issuance of common stock through employee benefit plans, shares	207
Share-based compensation			27,679			27,679
Purchase of option hedge on convertible notes			(42,895)			(42,895)
Equity portion of convertible notes issuance costs			(1,334)			(1,334)
Proceeds from equity component of convertible notes			43,170			43,170
Proceeds from the sale of stock purchase warrants			28,451			28,451
Repurchase of common stock		(83,463)				(83,463)
Repurchase of common stock, shares		(1,909)
Balance at Dec. 31, 2011	$ 357	$ (367,121)	$ 607,676	$ (9,093)	$ 260,819	$ 492,638
Balance, shares at Dec. 31, 2011	35,734	(8,903)

Business

12 Months Ended

Dec. 31, 2011

Business [Abstract]

Business

1.	BUSINESS

Integra LifeSciences Holdings Corporation (the "Company") was incorporated in Delaware in 1989. The Company, a world leader in medical devices, is dedicated to limiting uncertainty for surgeons through the development, manufacturing, and marketing of cost-effective surgical implants and medical instruments. Its products are used primarily in neurosurgery, extremity reconstruction, orthopedics and general surgery.

The Company sells its products directly through various sales forces and through a variety of other distribution channels.

Summary Of Significant Accounting Policies

12 Months Ended

Dec. 31, 2011

Summary Of Significant Accounting Policies [Abstract]

Summary Of Significant Accounting Policies

2.	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

BASIS OF PRESENTATION

These financial statements and the accompanying notes are prepared in accordance with accounting principles generally accepted in the United States of America and conform to Regulation S-X under the Securities Exchange Act of 1934, as amended.

PRINCIPLES OF CONSOLIDATION

The consolidated financial statements include the accounts of the Company and its subsidiaries, all of which are wholly owned. All significant intercompany accounts and transactions are eliminated in consolidation. See Note 3, "Acquisitions," for details of new subsidiaries included in the consolidation.

USE OF ESTIMATES

The preparation of consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenues and expenses. Significant estimates affecting amounts reported or disclosed in the consolidated financial statements include allowances for doubtful accounts receivable and sales returns and allowances, net realizable value of inventories, valuation of intangible assets and in-process research and development, amortization periods for acquired intangible assets, discount rates and estimated projected cash flows used to value and test impairments of long-lived assets and goodwill, estimates of projected cash flows and depreciation and amortization periods for long-lived assets, computation of taxes, valuation allowances recorded against deferred tax assets, the valuation of stock-based compensation, valuation of pension assets and liabilities, valuation of derivative instruments, valuation of the equity component of convertible debt instruments, valuation of debt instruments and loss contingencies. These estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the current circumstances. Actual results could differ from these estimates.

RECLASSIFICATIONS

Certain amounts from the prior years' financial statements have been reclassified in order to conform to the current year's presentation.

CASH AND CASH EQUIVALENTS

The Company considers all short term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE

Trade accounts receivable are recorded at the invoiced amount and do not bear interest. The Company grants credit to customers in the normal course of business, but generally does not require collateral or any other security to support its receivables.

The Company evaluates the collectability of accounts receivable based on a combination of factors. In circumstances where a specific customer is unable to meet its financial obligations to the Company, a provision to the allowances for doubtful accounts is recorded against amounts due to reduce the net recognized receivable to the amount that is reasonably expected to be collected. For all other customers, a provision to the allowances for doubtful accounts is recorded based on factors including the length of time the receivables are past due, the current business environment and the Company's historical experience. Provisions to the allowances for doubtful accounts are recorded to selling, general and administrative expenses. Account balances are charged off against the allowance when the Company feels it is probable that the receivable will not be recovered.

INVENTORIES

Inventories, consisting of purchased materials, direct labor and manufacturing overhead, are stated at the lower of cost, the value determined by the first-in, first-out method, or market. Inventories consisted of the following:


	December 31,
	2011		2010
	(In thousands)
Finished goods	$	106,972	$	87,508
Work in process		36,070		31,536
Raw materials		28,219		27,884

Total inventories, net	$	171,261	$	146,928

At each balance sheet date, the Company evaluates inventories for excess quantities, obsolescence or shelf-life expiration. This evaluation includes analyses of historical sales levels by product, projections of future demand, the risk of technological or competitive obsolescence for products, general market conditions, a review of the shelf life expiration dates for products, as well as the feasibility of reworking or using excess or obsolete products or components in the production or assembly of other products that are not obsolete or for which there are not excess quantities in inventory. To the extent that management determines there are excess or obsolete inventory or quantities with a shelf life that is too near its expiration for the Company to reasonably expect that it can sell those products prior to their expiration, the Company adjusts the carrying value to estimated net realizable value.

The Company capitalizes inventory costs associated with certain products prior to regulatory approval, based on management's judgment of probable future commercialization. The Company could be required to expense previously capitalized costs related to pre-approval inventory upon a change in such judgment, due to, among other potential factors, a denial or delay of approval by necessary regulatory bodies or a decision by management to discontinue the related development program. No such amounts were capitalized at December 31, 2011 or 2010.

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment are stated at cost. The Company provides for depreciation using the straight-line method over the estimated useful lives of the assets. Leasehold improvements are amortized over the lesser of the lease term or the useful life. The cost of major additions and improvements is capitalized, while maintenance and repair costs that do not improve or extend the lives of the respective assets are charged to operations as incurred.

Property, plant and equipment balances and corresponding lives were as follows:


	December 31,						Useful Lives
	2011			2010			Useful Lives
	(In thousands)
Land	$	2,709		$	2,726
Buildings and building improvements		7,376			6,964			5-40 years
Leasehold improvements		38,030			38,102			1-20 years
Machinery and production equipment		98,731			96,692			3-20 years
Furniture, fixtures, office equipment and information systems		52,363			45,406			1-15 years
Construction-in-progress		52,965			20,137

Total		252,174			210,027
Less: Accumulated depreciation		(120,791	)		(110,571	)

Property, plant and equipment, net	$	131,383		$	99,456

Depreciation expense associated with property, plant and equipment was $25.5 million, $21.3 million and $18.8 million for the years ended December 31, 2011, 2010 and 2009, respectively.

GOODWILL AND OTHER INTANGIBLE ASSETS

The excess of the cost over the fair value of net assets of acquired businesses is recorded as goodwill. Goodwill is not subject to amortization, but is reviewed for impairment at the reporting unit level annually, or more frequently if impairment indicators arise. The Company's assessment of the recoverability of goodwill is based upon a comparison of the carrying value of goodwill with its estimated fair value. No impairment of goodwill has been identified during any of the periods presented.

Changes in the carrying amount of goodwill in 2011 and 2010 were as follows:


	2011			2010
	(In thousands)
Goodwill	$	261,928		$	261,941
Accumulated impairment losses		—			—

Goodwill, beginning of year		261,928			261,941
Ascension Orthopedics, Inc. acquisition		15,909			—
SeaSpine Inc. acquisition		14,283			—
Integra Spine acquisition, earnout payment		1,200			3,400
Welch Allyn, Inc. acquisition		—			601
Integra Neurosciences Pty Ltd., earnout payment		1,059			1,016
Foreign currency translation and other		(1,399	)		(5,030	)

Goodwill, end of year	$	292,980		$	261,928

Identifiable intangible assets are initially recorded at fair market value at the time of acquisition generally using an income or cost approach. The Company capitalizes costs incurred to renew or extend the term of recognized intangible assets and amortizes those costs over their expected useful lives.

The components of the Company's identifiable intangible assets were as follows:


	December 31, 2011									December 31, 2010
	Weighted Average Life		Cost		Accumulated Amortization			Net		Weighted Average Life		Cost		Accumulated Amortization			Net
			(Dollars in thousands)									(Dollars in thousands)
Completed technology		11 years	$	75,990	$	(32,157	)	$	43,833		12 years	$	69,261	$	(28,062	)	$	41,199
Customer relationships		11 years		147,230		(57,348	)		89,882		12 years		99,290		(45,505	)		53,785
Trade names		32 years		33,669		(10,897	)		22,772		35 years		33,448		(8,467	)		24,981
Trade names		Indefinite		48,484		—			48,484		Indefinite		49,384		—			49,384
Supplier relationships		26 years		33,810		(5,389	)		28,421		30 years		29,300		(4,525	)		24,775
All other(1)		6 years		11,434		(7,704	)		3,730		15 years		8,440		(7,660	)		780

			$	350,617	$	(113,495	)	$	237,122			$	289,123	$	(94,219	)	$	194,904

(1)

At December 31, 2011, all other included in-process research and development of $1.7 million, which was indefinite lived. At December 31, 2010 all other included in-process research and development of $0.3 million which was indefinite lived; during the second quarter of 2011, this asset was placed in service as a component of completed technology.

During the second quarter of 2011 the Company identified one indefinite-lived trade name asset that it will no longer use as a result of its rebranding strategy, which resulted in an impairment of $0.9 million. This charge has been recorded as a component of amortization expense. The Company performs its assessment of the recoverability of indefinite-lived intangible assets annually during the second quarter, or more frequently as impairment indicators arise, and it is based upon a comparison of the carrying value of such assets to their estimated fair values. The Company performed its most recent annual assessment during the second quarter of 2011, which resulted in no additional impairments.

During the year ended December 31, 2011, the Company recorded impairment charges to finite-lived intangible assets of $2.1 million related to technology assets whose related products are being discontinued and $0.2 million related to a trade name that will no longer be used because of its rebranding strategy. The Company has recorded the charges as a component of cost of product revenues and amortization expense, respectively.

During the year ended December 31, 2010, the Company recorded a $0.8 million impairment charge to finite-lived intangible assets related to several trade names. The impairment charge relates to management's decision with respect to the Company's re-branding strategy for several legacy trade names. The Company has recorded the charge as a component of amortization expense.

During the year ended December 31, 2009, the Company recorded a $0.9 million impairment charge to finite-lived intangible assets related to a technology-based intangible asset as a component of its cost of product revenues. The impairment charge relates to decisions made by management to discontinue development of the related technology. The Company also recorded a $0.6 million impairment charge related to a trade name in connection with the revised expected benefit from the related trade name.

Amortization expense for the years ended December 31, 2011, 2010 and 2009 was $24.6 million, $17.9 million and $21.0 million, respectively. Annual amortization expense is expected to approximate $25.0 million in 2012, $19.1 million in 2013, $18.1 million in 2014, $16.2 million in 2015 and $14.0 million in 2016. Amortization of product technology-based intangible assets, which totaled $8.2 million, $5.9 million and $6.6 million for the years ended December 31, 2011, 2010 and 2009, respectively, is presented by the Company within cost of product revenues.

LONG-LIVED ASSETS

Long-lived assets held and used by the Company, including property, plant and equipment and intangible assets, are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. For purposes of evaluating the recoverability of long-lived assets to be held and used, a recoverability test is performed using projected undiscounted net cash flows applicable to the long-lived assets. If an impairment exists, the amount of such impairment is calculated based on the estimated fair value of the asset. Impairments to long-lived assets to be disposed of are recorded based upon the difference between the carrying value and the fair value of the applicable assets.

INTEGRA FOUNDATION

The Company may periodically make contributions to the Integra Foundation, Inc. The Integra Foundation was incorporated in 2002 exclusively for charitable, educational, and scientific purposes and qualifies under IRC 501(c)(3) as an exempt private foundation. Under its charter, the Integra Foundation engages in activities that promote health, the diagnosis and treatment of disease, and the development of medical science through grants, contributions and other appropriate means. The Integra Foundation is a separate legal entity and is not a subsidiary of the Company. Therefore, its results are not included in these consolidated financial statements. The Company contributed $0.3 million, $0.7 million and $0.6 million to the Integra Foundation during the years ended December 31, 2011, 2010 and 2009, respectively. These contributions were recorded in selling, general, and administrative expense.

DERIVATIVES

The Company develops, manufactures, and sells medical devices globally and its earnings and cash flows are exposed to market risk from changes in interest rates and currency exchange rates. The Company addresses these risks through a risk management program that includes the use of derivative financial instruments, and operates the program pursuant to documented corporate risk management policies. All derivative financial instruments are recognized in the financial statements at fair value in accordance with the authoritative guidance. Under the guidance, for those instruments that are designated and qualify as hedging instruments, the hedging instrument must be designated as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation, based on the exposure being hedged. The accounting for changes in the fair value of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and, further, on the type of hedging relationship. The Company's derivative instruments do not subject its earnings or cash flows to material risk, and gains and losses on these derivatives generally offset losses and gains on the item being hedged. The Company has not entered into derivative transactions for speculative purposes and from time to time, the Company may enter into derivatives that are not designated as hedging instruments in order to protect itself from currency volatility due to intercompany balances.

All derivative instruments are recognized at their fair values as either assets or liabilities on the balance sheet. The Company determines the fair value of its derivative instruments, using the framework prescribed by the authoritative guidance, by considering the estimated amount the Company would receive to sell or transfer these instruments at the reporting date and by taking into account: expected forward interest rates, currency exchange rates, the creditworthiness of the counterparty for assets, and its creditworthiness for liabilities. In certain instances, the Company utilizes a discounted cash flow model to measure fair value. Generally, the Company uses inputs that include quoted prices for similar assets or liabilities in active markets; other observable inputs for the asset or liability; and inputs derived principally from, or corroborated by, observable market data by correlation or other means. The Company has classified all of its derivative assets and liabilities within Level 2 of the fair value hierarchy because observable inputs are available for substantially the full term of its derivative instruments. The Company classifies derivatives that meet the definition of hedges in the same category as the item being hedged for cash flow presentation purposes.

FOREIGN CURRENCY

All assets and liabilities of foreign subsidiaries which have a functional currency other than the U.S. dollar are translated at the rate of exchange at year-end, while elements of the income statement are translated at the average exchange rates in effect during the year. The net effect of these translation adjustments is shown as a component of accumulated other comprehensive income (loss). These currency translation adjustments are not currently adjusted for income taxes as they relate to permanent investments in non-U.S. subsidiaries. Foreign currency transaction gains and losses are reported in Other income (expense), net.

INCOME TAXES

Income taxes are accounted by using the asset and liability method in accounting for income taxes. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. A valuation allowance is provided when it is more likely than not that some portion or all of the deferred tax assets will not be realized. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period when the change is enacted.

The Company recognizes a tax benefit from an uncertain tax position only if it is more likely than not to be sustained upon examination based on the technical merits of the position. Reserves are established for positions that don't meet this recognition threshold. The reserve is measured as the largest amount of benefit determined on a cumulative probability basis that the Company believes is more likely than not to be realized upon ultimate settlement of the position. These reserves are classified as long-term liabilities in the consolidated balance sheets of the Company. The Company also records interest and penalties accrued in relation to uncertain tax benefits as a component of income tax expense.

While the Company believes it has identified all reasonably identifiable exposures and the reserve it has established for identifiable exposures is appropriate under the circumstances, it is possible that additional exposures exist and that exposures may be settled at amounts different than the amounts reserved. It is also possible that changes in facts and circumstances could cause the Company to either materially increase or reduce the carrying amount of its tax reserve.

The Company's policy has been to leave its unremitted foreign earnings invested indefinitely outside the United States, and it intends to continue this policy. As such, taxes have not been provided on any of the remaining accumulated foreign unremitted earnings. Where it has become apparent that some or all of the undistributed earnings will be remitted in the foreseeable future, tax consequences are considered.

REVENUE RECOGNITION

Total revenues, net, include product sales, product royalties and other revenues, such as fees received under research, licensing, and distribution arrangements, research grants, and technology-related royalties.

Revenue is recognized when persuasive evidence of an arrangement exists, delivery has occurred and title and risk of loss have passed to the customer, there is a fixed or determinable sales price, and collectability of that sales price is reasonably assured. For product sales, the Company's stated terms are primarily FOB shipping point and with most customers, title and risk of loss pass to the customer at that time. With certain United States customers, the Company retains risk of loss until the customers receive the product, and in those situations, the Company recognizes revenue upon receipt by the customer.

Each revenue transaction is evidenced by either a contract with the customer or a valid purchase order and an invoice which includes all relevant terms of sale. There are generally no significant customer acceptance or other conditions that prevent the Company from recognizing revenue in accordance with its delivery terms. In certain cases, where the Company has performance obligations that are significant to the functionality of the product, the Company recognizes revenue upon fulfillment of its obligation.

Sales invoices issued to customers contain the Company's price for each product or service. The Company performs a review of each specific customer's credit worthiness and ability to pay prior to accepting them as a customer. Further, the Company performs periodic reviews of its customers' status prospectively.

The Company records a provision for estimated returns and allowances on revenues in the same period as the related revenues are recorded. These estimates are based on historical sales returns and discounts and other known factors. The provisions are recorded as a reduction to revenues.

The Company's return policy, as set forth in its product catalogs and sales invoices, requires the Company to review and authorize the return of product in advance. Upon authorization, a credit will be issued for goods returned within a set amount of days from shipment, which is generally ninety days.

Product royalties are estimated and recognized in the same period that the royalty-based products are sold by the Company's strategic partners. The Company estimates and recognizes royalty revenue based upon communication with licensees, historical information and expected sales trends. Differences between actual revenues and estimated royalty revenues are adjusted in the period in which they become known, which is typically the following quarter. Historically, such adjustments have not been significant.

Other operating revenues may include fees received under research, licensing, and distribution arrangements, technology-related royalties and research grants. Non-refundable fees received under research, licensing and distribution arrangements or for the licensing of technology are recognized as revenue when received if the Company has no continuing obligations to the other party. For those arrangements where the Company has continuing performance obligations, revenue is recognized using the lesser of the amount of non-refundable cash received or the result achieved using the proportional performance method of accounting based upon the estimated cost to complete these obligations. Research grant revenue is recognized when the related expenses are incurred.

SHIPPING AND HANDLING FEES AND COSTS

Amounts billed to customers for shipping and handling are included in revenues. The related shipping and freight charges incurred by the Company are included in cost of product revenues. Distribution and handling costs of $11.5 million, $9.6 million and $8.3 million were recorded in selling, general and administrative expense during the years ended December 31, 2011, 2010 and 2009, respectively.

PRODUCT WARRANTIES

Certain of the Company's medical devices, including monitoring systems and neurosurgical systems, are reusable and are designed to operate over long periods of time. These products are sold with warranties which may extend for up to two years from date of purchase. The Company accrues estimated product warranty costs at the time of sale based on historical experience. Any additional amounts are recorded when such costs are probable and can be reasonably estimated.

Accrued warranty expense consisted of the following:


	December 31,
	2011			2010
	(In thousands)
Beginning balance	$	548		$	632
Net change		(108	)		(84	)

Ending balance	$	440		$	548

RESEARCH AND DEVELOPMENT

Research and development costs, including salaries, depreciation, consultant and other external fees, and facility costs directly attributable to research and development activities, are expensed in the period in which they are incurred.

In-process research and development recorded in connection with acquisitions represent the value assigned to acquired assets to be used in research and development activities and for which there is no alternative use. Value is generally assigned to these assets based on the net present value of the projected cash flows expected to be generated by those assets.

During 2011 and 2010 the Company capitalized $1.7 million and $0.3 million of in-process research and development costs related to acquisitions. The Company recorded an in-process research and development charge of $0.3 million related to certain assets acquired from Innovative Spinal Technologies, Inc. during 2009. The 2009 charge was related to technology that had not yet reached feasibility and had no alternative future use.

EMPLOYEE TERMINATION BENEFITS AND OTHER EXIT-RELATED COSTS

The Company does not have a written severance plan, and it does not offer similar termination benefits to affected employees in all restructuring initiatives. Accordingly, in situations where minimum statutory termination benefits must be paid to the affected employees, the Company records employee severance costs associated with these restructuring activities in accordance with the authoritative guidance for non-retirement post-employment benefits. Charges associated with these activities are recorded when the payment of benefits is probable and can be reasonably estimated. In all other situations where the Company pays out termination benefits, including supplemental benefits paid in excess of statutory minimum amounts and benefits offered to affected employees based on management's discretion, the Company records these termination costs in accordance with the authoritative guidance for exit or disposal costs.

The timing of the recognition of charges for employee severance costs other than minimum statutory benefits depends on whether the affected employees are required to render service beyond their legal notification period in order to receive the benefits. If affected employees are required to render service beyond their legal notification period, charges are recognized ratably over the future service period. Otherwise, charges are recognized when management has approved a specific plan and employee communication requirements have been met.

For leased facilities and equipment that have been abandoned, the Company records estimated lease losses based on the fair value of the lease liability, as measured by the present value of future lease payments subsequent to abandonment, less the present value of any estimated sublease income on the cease-use date. For owned facilities and equipment that will be disposed of, the Company records impairment losses based on fair value less costs to sell. The Company also reviews the remaining useful life of long-lived assets following a decision to exit a facility and may accelerate depreciation or amortization of these assets, as appropriate.

STOCK-BASED COMPENSATION

The Company applies the authoritative guidance for stock-based compensation. This guidance requires companies to recognize the expense related to the fair value of their stock-based compensation awards. Stock-based compensation expense for stock option awards granted after January 1, 2006 was based on the fair value on the grant date using the binomial distribution model. The Company recognized compensation expense for stock option awards, restricted stock awards, performance stock awards and contract stock awards on a ratable basis over the requisite service period of the award. The long form method was used in the determination of the windfall tax benefit in accordance with the guidance.

PENSION BENEFITS

Defined benefit pension plans cover certain employees and retirees in the U.K. and former employees in Germany. Various factors are considered in determining the pension liability, including the number of employees expected to be paid their salary levels and years of service, the expected return on plan assets, the discount rate used to determine the benefit obligations, the timing of benefit payments and other actuarial assumptions. If the actual results and events for the pension plans differ from current assumptions, the benefit obligation may be over or under valued.

Retirement benefit plan assumptions are reassessed on an annual basis or more frequently if changes in circumstances indicate a re-evaluation of assumptions are required. The key benefit plan assumptions are the discount rate and expected rate of return on plan assets. The discount rate is based on average rates on bonds that matched the expected cash outflows of the benefit plans. The expected rate of return is based on historical and expected returns on the various categories of plan assets.

Pension contributions are expected to be consistent over the next few years since the Miltex plan was dissolved in 2008, and the Germany and U.K. plans are frozen. Contributions to the plans during the years ended December 31, 2011, 2010 and 2009 were $1.1 million, $1.1 million and $0.4 million, respectively.

CONCENTRATION OF CREDIT RISK

Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and cash equivalents, which are held at major financial institutions, investment-grade marketable debt securities and trade receivables.

The Company's products are sold on an uncollateralized basis and on credit terms based upon a credit risk assessment of each customer. A portion of the Company's trade receivables to customers outside the United States includes sales to foreign distributors, who then sell to government owned or supported healthcare systems. The current economic conditions in many southern European countries, especially Greece, Ireland, Italy, Portugal and Spain, have continued to deteriorate. Accounts receivable from customers in these countries was approximately $5.8 million at December 31, 2011, of which $0.8 million was reserved.

RECENTLY ISSUED ACCOUNTING STANDARDS

On September 15, 2011 the Financial Accounting Standards Board issued Accounting Standards Update No. 2011-08, Intangibles — Goodwill and Other (Topic 350), Testing Goodwill for Impairment. The revised standard is intended to reduce the cost and complexity of the annual goodwill impairment test by providing the option of performing a "qualitative" assessment to determine whether further impairment testing is necessary. Under this standard, the Company has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads to a determination that it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If, after assessing the totality of events or circumstances, the Company determines that it is not more likely than not that the fair value of a reporting unit is less than its carrying amount, performing the two-step impairment test under Topic 350 is unnecessary. However, if the Company concludes otherwise, it is required to perform the first step of the two-step impairment test, as described in Topic 350. If the carrying amount of a reporting unit exceeds its fair value under the first step, the Company is required to perform the second step of the goodwill impairment test to measure the amount of the impairment loss, if any. The Company also has the option to bypass the qualitative assessment for any reporting unit in any period and to proceed directly to performing the first step of the two-step goodwill impairment test. The Company may resume performing the qualitative assessment in any subsequent period. This standard is effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011, and early adoption is permitted. The Company believes that the adoption of this standard will not have a material impact on the Company's financial statements.

On June 16, 2011 the Financial Accounting Standards Board issued Accounting Standards Update No. 2011-05, Presentation of Comprehensive Income. This standard eliminates the option to report other comprehensive income and its components in the statement of changes in equity. The Company may elect to present items of net income and other comprehensive income in one continuous statement or in two consecutive statements. Each component of net income and each component of other comprehensive income, together with totals for comprehensive income and its two parts — net income and other comprehensive income — would need to be displayed under either alternative, and the statements would need to be presented with equal prominence as the other primary financial statements. This standard does not change 1) the items that constitute net income and other comprehensive income, 2) when an item of other comprehensive income must be reclassified to net income, or 3) the computation for earnings per share — which will continue to be based on net income. This standard is effective for fiscal years beginning after December 15, 2011. The adoption of this standard will not have an impact on the Company's operating results as the amendment impacts presentation only.

On May 12, 2011 the Financial Accounting Standards Board issued Accounting Standards Update No. 2011-04 — Fair Value Measurement (Topic 820): Amendments to Achieve Common Fair Value Measurement and Disclosure Requirements in U.S. GAAP and IFRS. This standard merges many aspects of fair value measurement guidance by amending U.S. GAAP and creating a new standard under International Financial Reporting Standards. The primary changes to U.S. GAAP include 1) clarifying the valuation premise of highest and best use, 2) clarifying how portfolios of financial instruments are measured, 3) clarifying the use of blockage factors and other premiums and discounts, and 4) increasing the disclosure requirements in a number of circumstances. This standard is effective for fiscal years beginning after December 15, 2011, and the Company believes the standard will not have a material impact on the Company's financial statements.

SUPPLEMENTAL CASH FLOW INFORMATION

Cash paid for interest for the years ended December 31, 2011, 2010 and 2009 was $13.2 million, $8.8 million and $11.3 million, respectively. Cash paid for income taxes for the years ended December 31, 2011, 2010 and 2009 was $14.5 million, $23.4 million and $20.5 million, respectively. Property and equipment purchases included in liabilities at December 31, 2011, 2010 and 2009 was $6.4 million, $1.1 million and $1.0 million, respectively.

During the year ended December 31, 2010, 282,086 stock options were exercised, whereby in lieu of a cash payment for the exercise price, an option holder tendered 73,546 shares of Company stock that had a fair market value of approximately $3.1 million. These tendered shares were then immediately retired.

In connection with the amendment and restatement of the Company's Senior Credit Facility during the year ended December 31, 2010, $150.0 million of the Company's revolving credit facility was converted into a term loan.

- Definition

The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 720

-SubTopic 15

-URI http://asc.fasb.org/subtopic&trid=2122524

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS140-4/FIN46(R)-8

-Paragraph 8, C1, C7

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2134480

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6970148&loc=SL6228881-111685

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2122150

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 2-6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Name Statement of Position (SOP)

-Publisher AICPA

-Number 94-6

-Paragraph 10

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Name FASB Interpretation (FIN)

-Publisher FASB

-Number 46R

-Paragraph 4, 14, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 205

-SubTopic 10

-Section 45

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6359553&loc=d3e288-107754

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2197480

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 810

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6921930&loc=d3e5614-111684

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 915

-SubTopic 235

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6472506&loc=d3e38932-110933

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 852

-SubTopic 10

-URI http://asc.fasb.org/subtopic&trid=2209116

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 272

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055

+ Details

Acquisitions

12 Months Ended

Dec. 31, 2011

Acquisitions [Abstract]

Acquisitions

3.	ACQUISITIONS

BUSINESS COMBINATIONS

Ascension Orthopedics, Inc.

On September 23, 2011, the Company acquired Ascension Orthopedics, Inc. ("Ascension") for $66.5 million, which includes amounts paid into escrow, subject to working capital adjustments. Ascension, based in Austin, Texas, develops and distributes a range of implants for the shoulder, elbow, wrist, hand, foot and ankle. Management determined the preliminary fair value of net assets acquired during the third quarter of 2011 as follows:


	Preliminary Purchase Price Allocation
	(Dollars in thousands)
Cash	$	627
Inventory		12,760
Accounts receivable		2,917
Other current assets		2,398
Property, plant and equipment		4,649
Other long-term assets		70
Deferred tax asset — long term		12,543
Intangible assets:			Wtd. Avg. Life:
Technology		7,885	10 years
Customer relationships		5,750	12 years
In-process research and development		1,739	Indefinite
Supplier relationship		4,510	10 years
Trade name		560	1 year
Goodwill		15,909

Total assets acquired		72,317
Accounts payable and other liabilities		5,827

Net assets acquired	$	66,490

Management determined the preliminary fair value of net assets acquired during the third quarter of 2011 and has not yet finalized the working capital adjustment. Measurement period adjustments included above reflect a decrease in the total fair value of inventory acquired, and a decrease in the value of long term deferred tax assets acquired. The measurement period adjustment was made to reflect facts and circumstances existing as of the acquisition date, and did not result from intervening events subsequent to the acquisition date. This adjustment did not have a significant impact on the Company's previously reported consolidated financial statements and, therefore, the Company has not retrospectively adjusted those financial statements.

The goodwill recorded in connection with this acquisition is based on (i) expected cost savings, operating synergies and other benefits expected to result from the combined operations, (ii) the value of the going-concern element of Ascension's existing business (that is, the higher rate of return on the assembled net assets versus if the Company had acquired all of the net assets separately), and (iii) intangible assets that do not qualify for separate recognition such as Ascension's assembled workforce. The goodwill acquired will not be deductible for tax purposes.

SeaSpine, Inc.

On May 23, 2011, the Company acquired all of the outstanding common stock of SeaSpine, Inc. ("SeaSpine") for $89.0 million, subject to indemnification holdbacks currently totaling $7.4 million, which are accrued at December 31, 2011 and certain working capital adjustments. The preliminary working capital adjustment reduced the purchase price above by $0.6 million in the fourth quarter of 2011. SeaSpine is based in Vista, California and designs, develops and manufactures spinal fixation products and bone substitute products.


	Preliminary Purchase Price Allocation
	(Dollars in thousands)
Cash	$	201
Inventory		14,900
Accounts receivable		7,608
Other current assets		623
Property, plant and equipment		9,177
Deferred tax asset — long term		302
Intangible assets:			Wtd. Avg. Life:
Technology		3,000	8 years
Customer relationships		41,200	13 years
Non-compete agreements		1,900	4 years
Trade name		300	1 year
Goodwill		14,283

Total assets acquired		93,494
Accounts payable and other liabilities		5,108

Net assets acquired	$	88,386

Management determined the preliminary fair value of net assets acquired during the second quarter of 2011 and has not yet finalized the working capital adjustment. Measurement period adjustments included above reflect a decrease in the total fair value of consideration transferred pursuant to a working capital adjustment provision of the purchase agreement. The measurement period adjustment was made to reflect facts and circumstances existing as of the acquisition date, and did not result from intervening events subsequent to the acquisition date. This adjustment did not have a significant impact on the Company's previously reported consolidated financial statements and, therefore, the Company has not retrospectively adjusted those financial statements.

The goodwill recorded in connection with this acquisition is based on (i) expected cost savings, operating synergies and other benefits expected to result from the combined operations, (ii) the value of the going-concern element of SeaSpine's existing business (that is, the higher rate of return on the assembled net assets versus if the Company had acquired all of the net assets separately), and (iii) intangible assets that do not qualify for separate recognition such as SeaSpine's assembled workforce. For tax purposes, the Company is treating the acquisition as an asset acquisition; therefore, the goodwill will be deductible for tax purposes.

Culley Investments Pty. Ltd.

In September 2010, the Company acquired certain assets as well as the distribution rights for its extremity reconstruction product lines in Australia from Culley Investments Pty. Ltd. ("Culley") for approximately $1.6 million (1.7 million Australian dollars) in cash. The Company has determined that this acquisition met the definition of a business under the authoritative guidance. For eight years, Culley has been the Company's distributor of these products in Australia. The acquisition provides the Company with the ability to sell orthopedic products directly to its Australian customers.


	Final Purchase Price Allocation
	(Dollars in thousands)
Inventory	$	878
Property, plant and equipment		319
Intangible assets — Customer relationships		373	Wtd. Avg. Life –12 years

Total net assets acquired	$	1,570

Welch Allyn, Inc.

In May 2010, the Company acquired certain assets and liabilities of the surgical headlight business of Welch Allyn, Inc. ("Welch") for approximately $2.4 million in cash and $0.2 million of working capital adjustments. The Company determined that this acquisition met the definition of a business under the authoritative guidance. The Company believes that the assets acquired will further its goal of expanding its reach into the surgical headlight market. The goodwill recorded in connection with this acquisition was based on the benefits the Company expects to generate from Welch's future cash flows and is not deductible for tax purposes.


	Final Purchase Price Allocation
	(Dollars in thousands)
Accounts receivable	$	518
Inventory		138
Property, plant and equipment		280
Intangible assets			Wtd. Avg. Life:
Customer relationships		490	15 years
Technology		263	6 years
In-Process research and development		312	Indefinite
Goodwill		601

Total net assets acquired	$	2,602

Integra Neurosciences Pty Ltd.

In October 2008, the Company acquired Integra Neurosciences Pty Ltd. in Australia and Integra Neurosciences Pty Ltd. in New Zealand for $4.0 million (6.0 million Australian dollars) in cash at closing, $0.3 million in acquisition expenses and working capital adjustments, and up to $2.1 million based on the exchange rates in effect at the time of the acquisition (3.1 million Australian dollars) in future payments based on the performance of business in the three years after closing. The Company paid approximately $0.9 million (1.0 million Australian dollars) of this potential revenue performance obligation in November 2009 for the first revenue performance year, and another $1.0 million (1.0 million Australian dollars) in December 2010 for the second revenue performance year. The Company paid $1.0 million (1.0 million Australian dollars) during the year ended December 31, 2011 for the third revenue performance year. There are no additional amounts due under this agreement.

Theken

In August 2008, the Company acquired Theken Spine, LLC, Theken Disc, LLC and Therics, LLC (collectively, "Integra Spine") for $75.0 million in cash, subject to certain adjustments, acquisition expenses of $2.4 million, working capital adjustments of $3.9 million, and up to $125.0 million in future payments based on the revenue performance of the business in each of the two years after closing. The Company paid approximately $52.0 million for the first-year revenue performance obligation in November 2009. From November 2009 through June 30, 2011 the Company had accrued a total of $4.6 million to settle a dispute related to a disagreement in the calculation of "trade sales" used in determining the revenue performance payment for the first year revenue performance obligation; the Company settled the dispute and paid this entire obligation in August 2011 (see Note 12, "Commitments and Contingencies"). There were no amounts due for the second performance year.

Pro Forma Results (unaudited)

The following unaudited pro forma financial information summarizes the results of operations for the years ended December 31, 2011 and 2010 as if the acquisitions completed by the Company during 2011 had been completed as of January 1, 2010. The acquisitions consummated during 2010 were not considered material and therefore, their impact has not been included below. The pro forma results are based upon certain assumptions and estimates, and they give effect to actual operating results prior to the acquisitions and adjustments to reflect (i) increased interest expense, depreciation expense, intangible asset amortization and fair value inventory step-up, (ii) decreases in certain expenses that will not be recurring in the post-acquisition entity, and (iii) income taxes at a rate consistent with the Company's statutory rate. No effect has been given to other cost reductions or operating synergies. The supplemental pro-forma earnings for the year ended December 31, 2011 were adjusted to exclude $4.3 million of pre-tax nonrecurring expenses that were included in the pro-forma earnings for the year ended December 31, 2010. These expenses included: acquisition-related costs, the fair value adjustment to acquisition-date inventory, and amortization. As a result, these pro forma results do not necessarily represent results that would have occurred if the acquisitions had taken place on the basis assumed above, nor are they indicative of the results of future combined operations.


	Year Ended December 31,
	2011		2010
	(In thousands, except per share amounts)
Total Revenue	$	811,933	$	800,476
Net income	$	23,236	$	51,818
Net income per share:
Basic	$	0.80	$	1.75
Diluted	$	0.79	$	1.71

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1497-128463

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1486-128463

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1392-128463

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1383-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6911361&loc=d3e6996-128479

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6911361&loc=d3e7000-128479

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1524-128463

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 88-16

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51, 52

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Appendix F

-Paragraph F4

-Subparagraph e

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 67-73

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6911361&loc=d3e6927-128479

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1490-128463

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6911361&loc=d3e7008-128479

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1500-128463

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

+ Details

Debt

12 Months Ended

Dec. 31, 2011

Debt [Abstract]

Debt

DEBT

2016 Convertible Senior Notes

On June 15, 2011, the Company issued $230.0 million aggregate principal amount of its 1.625% Convertible Senior Notes due 2016 (the "2016 Notes"). The 2016 Notes mature on December 15, 2016, and bear interest at a rate of 1.625% per annum payable semi-annually in arrears on December 15 and June 15 of each year. In accordance with the accounting guidance for debt with conversion and other options, the Company accounted for the liability and equity components of the 2016 Notes separately. The portion of the debt proceeds that the Company had classified as equity at the time of the offering, and recognized as a debt discount, was determined based on the fair value of similar debt instruments that do not include a conversion feature and amounted to $43.2 million. The Company is amortizing the debt discount to interest expense using the effective interest method through December 2016. The effective interest rate implicit in the liability component was based on the Company's estimated non-convertible borrowing rate at the date the 2016 Notes were issued and was 5.6%. In connection with this offering, the Company capitalized approximately $6.3 million of financing fees which includes amounts classified in equity.

The 2016 Notes are senior, unsecured obligations of the Company, and are convertible into cash and, if applicable, shares of its common stock based on an initial conversion rate, subject to adjustment of 17.4092 shares per $1,000 principal amount of 2016 Notes (which represents an initial conversion price of approximately $57.44 per share). The Company will satisfy any conversion of the 2016 Notes with cash up to the principal amount of the 2016 Notes pursuant to the net share settlement mechanism set forth in the indenture and, with respect to any excess conversion value, with shares of the Company's common stock. The 2016 Notes are convertible only in the following circumstances: (1) if the closing sale price of the Company's common stock exceeds 150% of the conversion price during a period as defined in the indenture; (2) if the average trading price per $1,000 principal amount of the 2016 Notes is less than or equal to 98% of the average conversion value of the 2016 Notes during a period as defined in the indenture; (3) at any time on or after June 15, 2016; or (4) if specified corporate transactions occur. The issue price of the 2016 Notes was equal to their face amount, which is also the amount holders are entitled to receive at maturity if the 2016 Notes are not converted. As of December 31, 2011, none of these conditions existed with respect to the 2016 Notes and as a result, the 2016 Notes are classified as long term.

Holders of the 2016 Notes who convert their notes in connection with a qualifying fundamental change, as defined in the related indenture, may be entitled to a make-whole premium in the form of an increase in the conversion rate. Additionally, following the occurrence of a fundamental change, holders may require that the Company repurchase some or all of the 2016 Notes for cash at a repurchase price equal to 100% of the principal amount of the notes being repurchased, plus accrued and unpaid interest, if any.

The 2016 Notes, under the terms of the private placement agreement, are guaranteed fully by Integra LifeSciences Corporation, a subsidiary of the Company. The 2016 Notes are the Company's direct senior unsecured obligations and rank equal in right of payment to all of the Company's existing and future unsecured and unsubordinated indebtedness.

In connection with the issuance of the 2016 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of such notes (the "hedge participants"). The cost of the call transactions to the Company was approximately $42.9 million, representing options to buy 4.0 million shares from the hedge participants at an initial strike price of $57.44 per share, subject to customary anti-dilution adjustments. These transactions are expected to reduce the potential dilution upon conversion of the 2016 Notes. The Company received approximately $28.5 million of proceeds from the warrant transactions, representing an obligation to potentially deliver 4.0 million shares to the hedge participants at an initial strike price of $70.05 per share, subject to customary anti-dilution adjustments. The earliest expiration of these warrant transactions is March 15, 2017 and they continue to expire through the 100th scheduled trading day thereafter, as defined in the indenture. The warrants could separately have a dilutive effect on the Company's earnings per share if the market price of its common stock exceeds the strike price of the warrants.

At December 31, 2011, the carrying amount of the liability component of the 2016 Notes was $190.6 million, the remaining unamortized discount was $39.4 million, and the principal amount outstanding was $230.0 million. The fair value of the 2016 Notes at December 31, 2011 was approximately $204.4 million.

Amended and Restated Senior Credit Agreement

On August 10, 2010, the Company entered into an amended and restated credit agreement (the "First Amendment) with a syndicate of lending banks and further amended the agreement on June 8, 2011 (the "Second Amendment", and collectively referred to herein as the "Senior Credit Facility"). The Second Amendment increased the revolving credit component from $450.0 million to $600.0 million and eliminated the $150.0 million term loan component that existed under the First Amendment, allows the Company to further increase the size of the revolving credit component by an aggregate of $200.0 million with additional commitments, provides the Company with decreased borrowing rates and annual commitment fees, and provides more favorable financial covenants. The Second Amendment extended the Senior Credit Facility's maturity date from August 10, 2015 to June 8, 2016. Both the First Amendment and the Second Amendment are collateralized by substantially all of the assets of the Company's U.S. subsidiaries, excluding intangible assets. The Company capitalized $1.3 million of incremental financing costs, expensed $0.4 million of incremental financing costs, and expensed $0.4 million of previously capitalized financing costs in connection with the Second Amendment. The Senior Credit Facility is subject to various financial and negative covenants and at December 31, 2011, the Company was in compliance with all such covenants.

Borrowings under the Senior Credit Facility bear interest, at the Company's option, at a rate equal to (i) the Eurodollar Rate (as defined in the Senior Credit Facility, which definition has not changed) in effect from time to time plus the applicable rate (ranging from 1.00% to 1.75% under the Second Amendment and from 1.75% to 2.50% under the First Amendment) or (ii) the highest of (x) the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.5%, (y) the prime lending rate of Bank of America, N.A. or (z) the one-month Eurodollar Rate plus 1.0%. The applicable rates are based on the Company's consolidated total leverage ratio (defined as the ratio of (a) consolidated funded indebtedness less cash in excess of $40 million that is not subject to any restriction of the use or investment thereof to (b) consolidated EBITDA) at the time of the applicable borrowing.

The Company also pays an annual commitment fee (ranging from 0.15% to 0.3% under the Second Amendment, and from 0.2% to 0.5% under the First Amendment, based on the Company's consolidated total leverage ratio) on the daily amount by which the revolving credit facility exceeds the outstanding loans and letters of credit under the credit facility.

On August 10, 2010, the Company also entered into an interest rate swap effective December 31, 2010 with an investment grade bank which converts a portion of the Company's variable interest payments to fixed interest payments (see Note 5, "Derivative Instruments").

At December 31, 2011, and 2010, there was $179.7 million and $100.0 million outstanding, respectively, under the revolving credit component of the Senior Credit Facility at a weighted average interest rate of 2.0% and 2.5%, respectively. At December 31, 2011, there was approximately $420.3 million available for borrowing under the Senior Credit Facility. The fair value of outstanding borrowings under the Senior Credit Facility at December 31, 2011 was approximately $162.2 million. The Company considers the balance to be long-term in nature based on its current intent and ability to repay the borrowing outside of the next twelve-month period.

At December 31, 2010, there was $148.1 million outstanding under the term loan component of the Senior Credit Facility at an interest rate of 2.6%, and as noted above, this portion of the credit facility was eliminated and replaced with borrowings under the revolving credit component in June 2011.

2010 and 2012 Senior Convertible Notes

On June 11, 2007, the Company issued $165.0 million aggregate principal amount under its 2010 Notes and $165.0 million aggregate principal amount under its 2012 Notes. The 2010 Notes and the 2012 Notes bear interest at a rate of 2.75% per annum and 2.375% per annum, respectively, in each case payable semi-annually in arrears on December 1 and June 1 of each year. In accordance with the accounting guidance for debt with conversion and other options, the Company accounted for the liability and equity components of the 2010 Notes and 2012 Notes separately. The portion of the debt proceeds that the Company had classified as equity at the time of the offering, and recognized as a debt discount, was determined based on the fair value of similar debt instruments that did not include a conversion feature and amounted to $16.4 million for the 2010 Notes and $30.6 million for the 2012 Notes. The Company is amortizing the debt discount to interest expense using the effective interest method through June 2010 for the 2010 Notes, and through June 2012 for the 2012 Notes. The effective interest rate implicit in the liability component was based on the Company's estimated non-convertible borrowing rate at the dates the 2010 and 2012 Notes were issued and was 6.5% for the 2010 Notes and 6.8% for the 2012 Notes. The 2010 Notes were repaid in June 2010 in accordance with their terms (see discussion of repurchases made during 2009 below).

The 2012 Notes are senior, unsecured obligations of the Company, and are convertible into cash and, if applicable, shares of its common stock based on an initial conversion rate, subject to adjustment of 15.3935 shares per $1,000 principal amount of notes for the 2012 Notes (which represents an initial conversion price of approximately $64.96 per share). The Company will satisfy any conversion of the 2012 Notes with cash up to the principal amount of the 2012 Notes pursuant to the net share settlement mechanism set forth in the indenture and, with respect to any excess conversion value, with shares of the Company's common stock. The 2012 Notes are convertible only in the following circumstances: (1) if the closing sale price of the Company's common stock exceeds 130% of the conversion price during a period as defined in the indenture; (2) if the average trading price per $1,000 principal amount of the 2012 Notes is less than or equal to 97% of the average conversion value of the 2012 Notes during a period as defined in the indenture; (3) at any time on or after December 15, 2011; or (4) if specified corporate transactions occur. The issue price of the 2012 Notes was equal to their face amount, which is also the amount holders are entitled to receive at maturity if the 2012 Notes are not converted.

Holders of the 2012 Notes, who convert their notes in connection with a qualifying fundamental change, as defined in the related indenture, may be entitled to a make-whole premium in the form of an increase in the conversion rate. Additionally, following the occurrence of a fundamental change, holders may require that the Company repurchase some or all of the 2012 Notes for cash at a repurchase price equal to 100% of the principal amount of the notes being repurchased, plus accrued and unpaid interest, if any.

The 2012 Notes, under the terms of the private placement agreement, are guaranteed fully by Integra LifeSciences Corporation, a subsidiary of the Company. The 2012 Notes will be the Company's direct senior unsecured obligations and will rank equal in right of payment to all of the Company's existing and future unsecured and unsubordinated indebtedness.

In connection with the issuance of the 2010 Notes and the 2012 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of such notes (the "hedge participants"). The total cost of the call transactions to the Company was approximately $46.8 million and the Company received approximately $21.7 million of proceeds from the warrant transactions. The call transactions involve the Company's purchasing call options from the hedge participants, and the warrant transactions involve the Company's selling call options to the hedge participants with a higher strike price than the purchased call options.

The initial strike price of the remaining call transactions is approximately $64.96 for the 2012 Notes, subject to anti-dilution adjustments. The initial strike price of the warrant transactions is (i) for the 2010 Notes, approximately $77.96 per share of Common Stock, which expired unexercised at various dates through January 2011, and (ii) for the 2012 Notes, approximately $90.95, subject to customary anti-dilution adjustments. The warrant transactions for the 2012 Notes expire on various dates between August 30, 2012 and January 23, 2013 and could separately have a dilutive effect on the Company's earnings per share if the market price of its common stock exceeds the strike price of the warrants.

At December 31, 2011, the carrying amount of the liability component of the 2012 Notes was $162.0 million, the remaining unamortized discount was $3.0 million, and the principal amount outstanding was $165.0 million. At December 31, 2010, the carrying amount of the liability component of the 2012 Notes was $155.2 million, the remaining unamortized discount was $9.8 million, and the principal amount outstanding was $165.0 million. The entire carrying amount of the 2012 Notes is classified as long-term in the December 31, 2011 balance sheet as the Company has the intent and ability to settle the obligation with long-term borrowings from its Senior Credit Facility. The fair value of the 2012 Notes at December 31, 2011 was approximately $163.8 million.

In 2009, the Company repurchased a portion of the 2010 Notes' principal outstanding for $32.1 million, $18.7 million, $17.7 million, and $18.6 million in March, June, September and December, respectively. The total cash paid for the Notes was $83.3 million, of which $78.0 million related to the repurchase of the liability component. The Company recognized a gain of $0.5 million on these repurchases. For all of these transactions the bond hedge contracts were terminated on a pro-rata basis and the number of options was adjusted to reflect the number of convertible securities outstanding that together have a total principal amount of $77.9 million. Also, in connection with the above repurchases, in separate transactions, the Company amended the warrant transactions to reduce the number of warrants outstanding to reflect such number of convertible securities outstanding.

Convertible Note Interest

The interest expense components of the Company's convertible notes are as follows:


	Year Ended December 31,
	2011		2010		2009
	(In thousands)
2016 Notes:
Non-cash interest	$	3,740	$	—	$	—
Cash Interest		2,024		—		—

Total	$	5,764	$	—	$	—


2012 Notes:
Non-cash interest	$	6,850	$	6,401	$	5,981
Cash Interest		3,919		3,919		3,919

Total	$	10,769	$	10,320	$	9,900


2010 Notes:
Non-cash interest	$	—	$	1,190	$	4,456
Cash Interest		—		830		3,587

Total	$	—	$	2,020	$	8,043

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

Derivative Instruments

12 Months Ended

Dec. 31, 2011

Derivative Instruments [Abstract]

Derivative Instruments

5.	DERIVATIVE INSTRUMENTS

Foreign Currency Hedging

From time to time the Company enters into foreign currency forward contracts designated as hedges, which are intended to protect the U.S. dollar value of certain forecasted foreign currency denominated transactions. The Company records the effective portion of any change in the fair value of foreign currency cash flow hedges in accumulated other comprehensive income ("AOCI"), net of tax, until the hedged item affects earnings. Once the related hedged item affects earnings, the Company reclassifies the effective portion of any related unrealized gain or loss on the foreign currency cash flow hedge to earnings. If the hedged forecasted transaction does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to earnings at that time.

The Company expects that $0.1 million of pre-tax losses relating to foreign currency forward contracts recorded as net in AOCI could be reclassified to earnings within the next twelve months.

The success of the Company's hedging program depends, in part, on forecasts of certain activity denominated in euros. The Company may experience unanticipated currency exchange gains or losses to the extent that there are differences between forecasted and actual activity during periods of currency volatility. In addition, changes in currency exchange rates related to any unhedged transactions may impact its earnings and cash flows.

Additionally, freestanding derivative foreign currency forward contracts may be used to offset the Company's exposure to the change in value of specific foreign currency denominated liabilities. These derivatives are not designated as hedges, and therefore, changes in the value of these forward contracts are immediately recognized in earnings thereby offsetting the effect of the related change in the U.S. dollar value of foreign currency denominated liabilities. The cash flows from these contracts are reported as operating activities in the consolidated statements of cash flows.

Interest Rate Hedging

The Company's interest rate risk relates to U.S. dollar denominated variable LIBOR interest rate borrowings. The Company uses an interest rate swap derivative instrument entered into on August 10, 2010 with an effective date of December 31, 2010 to manage its earnings and cash flow exposure to changes in interest rates by converting a portion of its floating-rate debt into fixed-rate debt beginning on December 31, 2010. This interest rate swap expires on August 10, 2015.

The Company designates this derivative instrument as a cash flow hedge. The Company records the effective portion of any change in the fair value of a derivative instrument designated as a cash flow hedge as unrealized gains or losses in AOCI, net of tax, until the hedged item affects earnings, at which point the effective portion of any gain or loss will be reclassified to earnings. If the hedged cash flow does not occur, or if it becomes probable that it will not occur, the Company will reclassify the amount of any gain or loss on the related cash flow hedge to interest expense at that time.

The Company expects that approximately $1.6 million of pre-tax losses related to the interest rate hedge recorded net in AOCI could be reclassified to earnings within the next twelve months.

Counterparty Credit Risk

The Company manages its concentration of counterparty credit risk on its derivative instruments by limiting acceptable counterparties to a group of major financial institutions with investment grade credit ratings, and by actively monitoring their credit ratings and outstanding positions on an on-going basis. Therefore, the Company considers the credit risk of the counterparties to be low. Furthermore, none of the Company's derivative transactions is subject to collateral or other security arrangements, and none contains provisions that are dependent on the Company's credit ratings from any credit rating agency.

Fair Value of Derivative Instruments

The following table summarizes the fair value, notional amounts presented in U.S. dollars, and presentation in the consolidated balance sheets for derivatives designated as hedging instruments as of December 31, 2011 and December 31, 2010:


	Fair Value as of				Notional Amount as of
Location on Balance Sheet (a):	December 31, 2011		December 31, 2010		December 31, 2011		December 31, 2010
	(In thousands)
Derivatives designated as hedges — Assets:
Interest rate swap — Other assets(b)	$	—	$	1,825

Derivatives designated as hedges — Liabilities:
Interest rate swap — Accrued expenses and other current liabilities(b)	$	1,634	$	2,095
Foreign currency foward contracts — Accrued expenses and other current liabilities		108		—	$	1,597	$	—
Interest rate swap — Other liabilities(b)		2,458		—

Total Derivatives designated as hedges — Liabilities	$	4,200	$	2,095

(a)	The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12 months.

(b)	At December 31, 2011 and 2010, the total notional amount related to the interest rate swap was $139.7 million and $148.1 million, respectively. In the subsequent twelve months the Company expects to reduce these amounts by $12.2 million and $8.4 million, respectively.

The following presents the pre-tax effect of derivative instruments designated as cash flow hedges on the accompanying consolidated statements of operations during the years ended December 31, 2011 and 2010:


	Amount of Gain (Loss) Recognized in AOCI (Effective Portion)			Amount of Gain (Loss) Reclassified from AOCI Into Earnings (Effective Portion)			Location in Statements of Operations
	(In thousands)
Year Ended December 31, 2011
Foreign currency forward contracts	$	(216	)	$	—		Cost of product revenue
Interest rate swap		(6,090	)		(2,269	)	Interest (expense)

	$	(6,306	)	$	(2,269	)

Year Ended December 31, 2010
Foreign currency forward contracts	$	2,756		$	2,782		Other income (expense)
Interest rate swap		(270	)		—		Interest (expense)

	$	2,486		$	2,782

The Company recognized no gains or losses due to ineffectiveness for the years ended December 31, 2011 and 2010.

As of December 31, 2011, the gross notional amount of derivative forward contracts outstanding that were not designated as hedging instruments was $3.3 million and there were no such contracts outstanding at or during the year ended December 31, 2010. The fair value of these forward contracts at December 31, 2011 was less than $0.1 million, which was recorded in other current assets. The impact on the consolidated statements of operations from derivative instruments not designated as hedges for the year ended December 31, 2011 was a $0.3 million loss recorded in other income (expense), net.

- Definition

The entire disclosure for the entity's entire derivative instruments and hedging activities. Describes an entity's risk management strategies, derivatives in hedging activities and non-hedging derivative instruments, the assets, obligations, liabilities, revenues and expenses arising therefrom, and the amounts of and methodologies and assumptions used in determining the amounts of such items.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4H

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624258-113959

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4K

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5708775-113959

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41641-113959

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(n))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4E

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624181-113959

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41635-113959

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4D

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624177-113959

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6441202&loc=d3e80720-113993

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6887037&loc=d3e80748-113994

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41620-113959

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4A

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5618551-113959

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4J

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5708773-113959

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 25

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6886632&loc=d3e76258-113986

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 45

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 133

-Paragraph 44

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6887037&loc=d3e80784-113994

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1A

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579245-113959

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4B

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624163-113959

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4C

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5624171-113959

Reference 20: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6935481&loc=d3e41638-113959

Reference 21: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1B

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5580258-113959

Reference 22: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 815

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6935481&loc=SL5579240-113959

+ Details

Treasury Stock

12 Months Ended

Dec. 31, 2011

Treasury Stock [Abstract]

Treasury Stock

6.	TREASURY STOCK

On October 30, 2008, the Company's Board of Directors authorized the Company to repurchase shares of its common stock for an aggregate purchase price not to exceed $75.0 million through December 31, 2010 (the "2008 Authorization").On October 29, 2010, the Company's Board of Directors terminated the 2008 Authorization and authorized the Company to repurchase shares of the Company's common stock for an aggregate purchase price not to exceed $75.0 million through December 31, 2012 (the "2010 Authorization").Shares may be purchased either in the open market or in privately negotiated transactions under both of these authorizations. As of December 31, 2011, there remained $29.1 million available for share repurchases under the 2010 Authorization. In addition to the authorizations above, on June 3, 2011, the Company's Board of Directors separately authorized the Company to repurchase shares of common stock from the proceeds of the 2016 Notes in connection with that offering.

The following table sets forth the Company's treasury stock activity:


	Years Ended December 31,
	2011				2010
	$		# of Shares		$		# of Shares
	(In thousands)
Shares repurchased in the open market in connection with the 2008 Authorization	$	—		—	$	31,278		858
Shares repurchased in the open market in connection with the 2010 Authorization		45,893		1,104		—		—
Shares repurchased in connection with the issuance of the 2016 Notes		37,570		805		—		—

Total	$	83,463		1,909	$	31,278		858

There were no treasury stock repurchases during the year ended December 31, 2009.

Stock Purchase And Award Plans

12 Months Ended

Dec. 31, 2011

Stock Purchase And Award Plans [Abstract]

Stock Purchase And Award Plans

7.	STOCK PURCHASE AND AWARD PLANS

Employee stock-based compensation expense recognized under the authoritative guidance was as follows:


	Years Ended December 31,
	2011		2010		2009
	(In thousands)
Selling, general and administrative	$	26,310	$	16,694	$	14,958
Research and development expense		404		426		492
Cost of product revenues		91		89		130

Total employee stock-based compensation expense		26,805		17,209		15,580
Total tax benefit related to employee stock-based compensation expense		10,468		7,006		6,253

Net effect on net income	$	16,337	$	10,203	$	9,327

EMPLOYEE STOCK PURCHASE PLAN

The purpose of the Employee Stock Purchase Plan (the "ESPP") is to provide eligible employees of the Company with the opportunity to acquire shares of common stock at periodic intervals by means of accumulated payroll deductions. Under the ESPP, a total of 1.5 million shares of common stock are reserved for issuance. These shares will be made available either from the Company's authorized but unissued shares of common stock or from shares of common stock reacquired by the Company as treasury shares. At December 31, 2011, 1.1 million shares remain available for purchase under the ESPP. During the years ended December 31, 2011, 2010 and 2009, the Company issued 8,523 shares, 5,515 shares and 7,263 shares under the ESPP for $0.2 million, $0.2 million and $0.3 million, respectively.

The ESPP was amended in 2005 to reduce the discount available to participants to five percent and to fix the price against which such discount would be applied. Accordingly, the ESPP is a non-compensatory plan.

EQUITY AWARD PLANS

As of December 31, 2011, the Company had stock options, restricted stock awards, and contract stock outstanding under six plans, the 1996 Incentive Stock Option and Non-Qualified Stock Option Plan (the "1996 Plan"), the 1998 Stock Option Plan (the "1998 Plan"), the 1999 Stock Option Plan (the "1999 Plan"), the 2000 Equity Incentive Plan (the "2000 Plan"), the 2001 Equity Incentive Plan (the "2001 Plan"), and the 2003 Equity Incentive Plan (the "2003 Plan", and collectively, the "Plans"). No new awards may be granted under the 1996 Plan, the 1998 Plan or the 1999 Plan.

In July 2008 and May 2010, the stockholders of the Company approved amendments to the 2003 Plan to increase by 750,000 and 1,750,000, respectively, the number of shares of common stock that may be issued under the 2003 Plan. The Company has reserved 750,000 shares of common stock for issuance under the 1996 Plan, 1,000,000 shares under the 1998 Plan, 2,000,000 shares under each of the 1999 Plan, the 2000 Plan and the 2001 Plan, and 6,500,000 shares under the 2003 Plan. The 1996 Plan, 1998 Plan, and the 1999 Plan permit the Company to grant both incentive and non-qualified stock options to designated directors, officers, employees and associates of the Company. In general, the 2000 Plan, 2001 Plan, and 2003 Plan permit the Company to grant incentive and non-qualified stock options, stock appreciation rights, restricted stock, contract stock, performance stock, or dividend equivalent rights to designated directors, officers, employees and associates of the Company. Stock options issued under the Plans become exercisable over specified periods, generally within four years from the date of grant for officers, employees and consultants, and generally expire six years from the grant date. The transfer and non-forfeiture provisions of restricted stock issued under the Plans lapse over specified periods, generally at three years after the date of grant.

Stock Options

The Company values stock option grants using the binomial distribution model. Management believes that the binomial distribution model is preferable to the Black-Scholes model because the binomial distribution model is a more flexible model that considers the impact of non-transferability, and vesting provisions in the valuation of employee stock options.

In determining the value of stock options granted, the Company considered that it has never paid cash dividends and does not currently intend to pay cash dividends, and thus has assumed a 0% dividend yield. Expected volatilities are based on the historical volatility of the Company's stock price with forward-looking assumptions. The expected life of stock options is estimated based on historical data on exercise of stock options, post-vesting forfeitures and other factors to estimate the expected term of the stock options granted. The risk-free interest rates are derived from the U.S. Treasury yield curve in effect on the date of grant for instruments with a remaining term similar to the expected life of the options. In addition, the Company applies an expected forfeiture rate when amortizing stock-based compensation expenses. The estimate of the forfeiture rates is based primarily upon historical experience of employee turnover. As individual grant awards become fully vested, stock-based compensation expense is adjusted to recognize actual forfeitures. The following weighted-average assumptions were used in the calculation of fair value:


	Years Ended December 31,
	2011	2010	2009
Dividend yield	0%	0%	0%
Expected volatility	28%	30%	29%
Risk free interest rate	2.47%	2.82%	2.0%
Expected life of option from grant date	8 years	8 years	8 years

The following table summarizes the Company's stock option activity:


Stock Options	Shares			Weighted Average Exercise Price		Weighted Average Contractual Term in Years		Aggregate Intrinsic Value
	(In thousands)							(In thousands)
Outstanding at December 31, 2010		1,560			$38.13
Granted		34			50.78
Exercised		(100	)		34.43
Forfeited or Expired		(11	)		36.60

Outstanding at December 31, 2011		1,483			$38.68		4.4		$270

Vested or expected to vest at December 31, 2011		1,483			$38.68		4.4		$270

Exercisable at December 31, 2011		1,465			$38.54		4.4		$270

The intrinsic value of options exercised for the years ended December 31, 2011, 2010 and 2009 was $1.4 million, $14.4 million and $1.0 million, respectively. The weighted average grant date fair value of options granted during the years ended December 31, 2011, 2010 and 2009 was $19.18, $17.03 and $8.12, respectively. Cash received from option exercises was $3.7 million, $16.1 million and $6.6 million, for the years ended December 31, 2011, 2010 and 2009, respectively.

As of December 31, 2011, there was approximately $0.2 million of total unrecognized compensation costs related to unvested stock options. These costs are expected to be recognized over a weighted-average period of approximately one year.

Awards of Restricted Stock, Performance Stock and Contract Stock

The following table summarizes the Company's awards of restricted stock, performance stock and contract stock for the year ended December 31, 2011:


	Restricted Stock Awards					Performance Stock and Contract Stock Awards
	Shares			Wtd. Avg. Grant Date Fair Value Per Share		Shares			Wtd. Avg Grant Date Fair Value Per Share
	(In thousands)			(In thousands)
Unvested, December 31, 2010		413			$34.98		277			$40.74
Granted		122			47.48		361			40.29
Cancellations		(35	)		37.99		(6	)		40.66
Released		(195	)		36.95		(9	)		44.51
Vested but not released		—			—		(479	)		43.83

Unvested, December 31, 2011		305			$38.37		144			$29.15

The Company recognized $24.5 million, $13.5 million and $10.5 million in expense related to such awards during the years ended December 31, 2011, 2010 and 2009, respectively. The total fair market value of shares vested in 2011, 2010 and 2009 was $29.7 million, $11.5 million and $4.7 million, respectively.

Performance stock awards have performance features associated with them. Performance stock, restricted stock and contract stock awards generally have requisite service periods of three years. The fair value of these awards is being expensed on a straight-line basis over the vesting period. As of December 31, 2011, there was approximately $7.4 million of total unrecognized compensation costs related to unvested awards. These costs are expected to be recognized over a weighted-average period of approximately two years.

In July 2004, the Company renewed the employment agreement of its former Chief Executive Officer ("the Executive") and the Executive received fully vested Restricted Units providing for the payment of 750,000 shares of Integra common stock which shall generally be delivered to the Executive following his termination of employment or retirement, or i) later under certain circumstances, ii) earlier if he is terminated without cause, or iii) if he leaves his position for good reason or upon a change of control or certain tax related events. In August 2008, the Company and the Executive renewed the Executive's employment agreement through December 31, 2011. In connection with the renewal of the agreement, the Executive received fully vested Restricted Units providing for the payment of 375,000 shares of Integra common stock which shall be delivered to the Executive within three business days following the first business day after the six month anniversary of his separation of service from the Company. As the Restricted Units vested on the grant date, a charge of approximately $18.0 million was recognized upon issuance, which was included in selling, general and administrative expenses. On May 17, 2011, in connection with the extension of the employment agreement with the Executive, the Company provided a grant of 165,000 contract stock/stock units ("SUs"). As the SUs vested at the grant date, the Company recognized a charge of approximately $8.4 million upon issuance, which was included in selling, general and administrative expenses. The Executive's employment contract provides for an annual equity award covering between 75,000 and 100,000 shares of the Company's stock. In December 2011, the Executive provided a letter to the Board of Directors acknowledging that the annual equity award that the Company determines to grant to him for 2011 may be granted in the first quarter of 2012 (rather than in December 2011). Because the Company is required to grant him an award for 2011 covering at least 75,000 shares, those shares have been included as part of the grants in the table above. The award is deemed to be fully vested under the Executive's contract as a result of the appointment of a new chief executive officer; therefore, the Company immediately recognized an expense of $2.3 million in 2011. Additionally, the Company's former chief executive officer's previously unvested awards immediately vested upon the appointment of a new chief executive officer, which resulted in an expense of $2.6 million in 2011. The Restricted Units granted in 2004, 2008 and 2011 were granted under the 2003 Plan, and as of December 31, 2011 the related shares have not been issued. The Executive has demand registration rights under the Restricted Unit grants.

At December 31, 2011, in addition to the Restricted Units discussed above, there are approximately 430,000 additional vested Restricted Units held by various employees for which the related shares have not yet been issued. Included in this amount are 34,868 units granted in October 2010 in connection with the Company's hiring of its Chief Executive Officer for which the Company immediately expensed $1.5 million as these shares were fully vested at the date of grant.

At December 31, 2011, there were approximately 1.9 million shares available for grant under the Plans.

- Definition

The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 123R

-Paragraph 64, 65, A240

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Statement of Position (SOP)

-Number 93-6

-Paragraph 53

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 14

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 50

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6406099&loc=d3e25284-112666

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 718

-SubTopic 40

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6418621&loc=d3e17540-113929

+ Details

Retirement Benefit Plans

12 Months Ended

Dec. 31, 2011

Retirement Benefit Plans [Abstract]

Retirement Benefit Plans

8.	RETIREMENT BENEFIT PLANS

DEFINED BENEFIT PLANS

The Company recognizes the overfunded or underfunded status of a defined benefit postretirement plan as an asset or liability in its statement of financial position and recognizes changes in that funded status in the year in which the changes occur through comprehensive income.

The Company maintains defined benefit pension plans that cover employees in its manufacturing plants located in Andover, United Kingdom (the "UK Plan") and Tuttlingen, Germany (the "Germany Plan"). The Company closed the Tuttlingen, Germany plant in December 2005. However, the Germany Plan was not terminated and the Company remains obligated for the accrued pension benefits related to this plan. The plans cover certain current and former employees. The plans are no longer open to new participants. The Company uses a December 31 measurement date for all of its pension plans.

Effective March 31, 2011, the Company froze the benefits due to the participants of the UK Plan in their entirety; this curtailment resulted in a $0.3 million reduction in the projected benefit obligations which the Company recorded on that date. The Company recorded the entire curtailment gain as an offset to the unrecognized net actuarial loss in accumulated other comprehensive income; therefore, this gain had no impact on the consolidated statements of operations.

Net periodic benefit costs for these defined benefit pension plans included the following amounts:


	Years Ended December 31,
	2011			2010			2009
	Non U.S. Plans			Non U.S. Plans			Non U.S. Plans
	(In thousands)
Service cost	$	26		$	93		$	121
Interest cost		650			645			605
Expected return on plan assets		(589	)		(515	)		(413	)
Recognized net actuarial loss		—			86			307

Net periodic benefit cost	$	87		$	309		$	620

The following weighted average assumptions were used to develop net periodic pension benefit cost and the actuarial present value of projected pension benefit obligations:


	Years Ended December 31,
	2011			2010			2009
	Non U.S. Plans			Non U.S. Plans			Non U.S. Plans
Discount rate		4.7	%		5.4	%		5.9	%
Expected return on plan assets		2.9	%		5.2	%		5.4	%
Rate of compensation increase		—	%		3.4	%		3.7	%

The expected return on plan assets represents the average rate of return expected to be earned on plan assets over the period the benefits included in the benefit obligation are to be paid. In developing the expected rate of return, the Company considers long-term compound annualized returns of historical market data as well as actual returns on the plan assets and applies adjustments that reflect more recent capital market experience. Using this reference information, the long-term return expectations for each asset category are developed according to the allocation among those investment categories. In 2011, 2010 and 2009, the discount rate was prescribed as the current yield on corporate bonds with an average rating of AA of equivalent currency and term to the liabilities.

The following sets forth the change in projected benefit obligations and the change in plan assets for the years ended December 31, 2011 and 2010 and a reconciliation of the funded status at December 31, 2011 and 2010:


	December 31,
	2011			2010
	Non-U.S. Plans			Non-U.S. Plans
	(In thousands)
CHANGE IN PROJECTED BENEFIT OBLIGATION
Projected benefit obligation, beginning of year	$	12,042		$	11,550
Service cost		26			93
Interest cost		650			645
Participant contributions		5			17
Benefits paid		(688	)		(464	)
Actuarial loss (gain)		610			551
Curtailment gain		(116	)		—
Effect of foreign currency exchange rates		27			(350	)

Projected benefit obligation, end of year	$	12,556		$	12,042

CHANGE IN PLAN ASSETS
Plan assets at fair value, beginning of year	$	10,834		$	9,302
Actual return on plan assets		1,970			1,070
Employer contributions		1,115			1,157
Participant contributions		11			17
Benefits paid		(678	)		(444	)
Effect of foreign currency exchange rates		(26	)		(268	)

Plan assets at fair value, end of year	$	13,226		$	10,834



	December 31,
	2011			2010
	Non-U.S. Plans			Non-U.S. Plans
	(In thousands)
RECONCILIATION OF FUNDED STATUS
Funded status, projected benefit obligation in excess of (less than) plan assets	$	670		$	(1,208	)
Unrecognized net actuarial loss		199			1,061
Accumulated other comprehensive loss		(199	)		(1,061	)

Amounts recognized	$	670		$	(1,208	)

The net asset position at December 31, 2011 is included in other assets. The accrued benefit liability at December 31, 2010 is included in other liabilities, except for the current portion which is included in accrued expenses and other current liabilities.

The combined accumulated benefit obligation for the defined benefit plans was $12.6 million and $11.9 million as of December 31, 2011 and 2010, respectively.

The investment strategy for the Company's defined benefit plans is both to meet the liabilities of the plans as they fall due and to maximize the return on invested assets within appropriate risk tolerances. The U.K. Plan invests in pooled funds which provide a diversification that supports the overall investment objectives. The Germany Plan had no assets at December 31, 2011 or December 31, 2010.

Based on the assets which comprise each of the funds, the weighted-average allocation of plan assets by asset category is as follows:


	December 31,
	2011			2010
	Non-U.S. Plans			Non-U.S. Plans
Equity securities		—	%		19	%
Corporate bonds		—	%		33	%
Government bonds		97	%		46	%
Cash		3	%		2	%

		100	%		100	%

The fair value of the Company's pension plan assets at December 31, 2011 and 2010 is as follows:


		Fair Value Measurements at December 31, 2011:
Manager/Fund	Asset Category	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
		(In thousands)
Bank account	Cash	$	344		$344		$ —		$—
Legal & General Index-Linked Gilts Index (various tenors)(c)	Index-linked government bonds		11,117		—		11,117		—
Legal & General Over 15 Year Gilts Index(d)	Government bonds		1,765		—		1,765		—

Total		$	13,226		$344		$12,882		$—


		Fair Value Measurements at December 31, 2010:
Manager/Fund	Asset Category	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
		(In thousands)
Bank account	Cash	$	254		$254		$ —		$—
Baillie Gifford-Managed Pension Fund(a)	Equity securities		2,012		—		2,012		—
	Corporate bonds		134		—		134		—
	Cash		46		46		—		—
Baillie Gifford-Investment Grade Long Bond Fund(b)	Corporate bonds		3,439		—		3,439		—
Legal & General Over 15 Year Index-Linked Gilts Index(c)	Index-linked government bonds		4,949		—		4,949		—

Total		$	10,834		$300		$10,534		$—

(a)	This category represents a pooled fund consisting of holdings in a range of UK and overseas equities and bonds, and cash.

(b)	This category represents a diversified portfolio of investment-grade fixed-interest securities.

(c)	This category represents funds consisting of index-linked gilts and is designated to follow a benchmark index.

(d)	This category represents a fund consisting of gilts and is designed to follow a benchmark index.

The Level 2 investments are single priced. The fund prices are calculated by the trustee by taking the closing market price of each underlying investment using a variety of independent pricing sources (i.e., quoted market prices). The prices also include income receivable and expenses payable, where applicable.

Based on year-end exchange rates, the Company anticipates contributing approximately $0.8 million to its defined benefit plans in 2012. Also based on year-end exchange rates, the Company expects to pay the following estimated future benefit payments in the years indicated:


	Expected Future Benefit Payments
	(In thousands)
2012		$	480
2013			518
2014			549
2015			583
2016			614
2017-2021			3,520

Included in Accumulated Other Comprehensive Income is $0.2 million of unrecognized net actuarial loss, a portion of which is expected to be recognized as a component of net periodic benefit cost in 2012.

DEFINED CONTRIBUTION PLANS

The Company also has various defined contribution savings plans that cover substantially all employees in the United States, the United Kingdom and Puerto Rico. The Company matches a certain percentage of each employee's contributions as per the provisions of the plans. Total contributions by the Company to the plans were $2.4 million, $2.0 million and $1.7 million for the years ended December 31, 2011, 2010 and 2009, respectively.

- Definition

The entire disclosure for pension and other postretirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Implementation Guide (Q and A)

-Number FAS88

-Paragraph 63

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-URI http://asc.fasb.org/topic&trid=2235017

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 158

-Paragraph 7, 21, 22

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5, 6, 7, 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph h

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph q

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 8

-Subparagraph m

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 03-2

-Paragraph 8

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Principles Board Opinion (APB)

-Number 30

-Paragraph 26

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Staff Position (FSP)

-Number FAS106-2

-Paragraph 20, 21, 22

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

Leases And Related Party Leases

12 Months Ended

Dec. 31, 2011

Leases And Related Party Leases

9.	LEASES AND RELATED PARTY LEASES

The Company leases administrative, manufacturing, research and distribution facilities and various manufacturing, office and transportation equipment through operating lease agreements. Future minimum lease payments under operating leases at December 31, 2011 were as follows:


	Related Parties		Third Parties		Total
	(In thousands)
2012	$	1,009	$	11,103	$	12,112
2013		1,027		10,157		11,184
2014		1,027		8,780		9,807
2015		974		5,286		6,260
2016		974		2,468		3,442
Thereafter		1,879		3,516		5,395

Total minimum lease payments	$	6,890	$	41,310	$	48,200

Total rental expense for the years ended December 31, 2011, 2010 and 2009 and was $9.3 million, $8.2 million and $8.1 million, respectively, and included $0.9 million, $0.8 million and $0.9 million in related party rental expense, respectively.

Related Party Leases

The Company leases certain production equipment from a corporation whose sole stockholder is a general partnership, of which the Company's former Chairman (and current director) is a partner and the President. The term of the lease is through March 31, 2022, and the Company has an option to renew through March 31, 2032. Under the terms of the lease agreement, the Company pays $0.1 million per year to the related party lessor. The Company also leases its manufacturing facility in Plainsboro, New Jersey, from a general partnership that is 50% owned by a corporation whose shareholders are trusts, whose beneficiaries include family members of the Company's former Chairman (and current director). The term of the current lease agreement is through October 31, 2017 at an annual rate of approximately $0.3 million per year. The current lease agreement also provides (i) a fifteen-year option for the Company to extend the lease from November 1, 2017 through October 31, 2032 at an annual rate of approximately $0.3 million per year and, (ii) a five-year option for the Company to extend the lease from November 1, 2032 through October 31, 2037 at the then fair market value rental rate, and (iii) another five-year option to extend the lease from November 1, 2037 through October 31, 2042 at the then fair market rental rate.

- Definition

The entire disclosure for operating leases of a lessor. This may inlcude a general description of lessor's leasing arrangements for operating leases, including the basis on which contingent rental payments are determined, the existence and terms of renewal or purchase options and escalation clauses, restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions.

+ References+ Details

Income Taxes

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Income Taxes

10.

INCOME TAXES

Income before income taxes consisted of the following:


	Years Ended December 31,
	2011		2010		2009
	(In thousands)
United States operations	$	1,507	$	37,026	$	40,497
Foreign operations		26,987		45,088		32,655

Total	$	28,494	$	82,114	$	73,152

A reconciliation of the U.S. Federal statutory rate to the Company's effective tax rate is as follows:


	Years Ended December 31,
	2011			2010			2009
Federal statutory rate		35.0	%		35.0	%		35.0	%
Increase (reduction) in income taxes resulting from:
State income taxes, net of federal tax benefit		6.0	%		2.6	%		2.6	%
Foreign operations		(18.1	)%		(10.3	)%		(9.9	)%
Incentive stock option expense		—	%		(0.3	)%		(0.2	)%
Change in valuation allowances		(14.0	)%		1.7	%		4.4	%
Uncertain tax positions		(5.8	)%		(4.6	)%		—	%
Other		(1.3	)%		(4.1	)%		(1.6	)%

Effective tax rate		1.8	%		20.0	%		30.3	%

During the second quarter of 2011 the Company recorded additional tax expense of $1.7 million for a correction to a state deferred tax asset relating to 2009. During the fourth quarter of 2011 the Company recorded an income tax benefit of $2.2 million for the correction of various other deferred tax items relating to periods prior to 2011 that largely impacted foreign operations. Since neither one of these changes are material to the current or previous years' financial results, they have been recorded in the second and fourth quarters of 2011, respectively.

In the fourth quarter of 2010, the Company recorded the full year income tax benefit related to the passing of the Tax Relief, Unemployment Insurance Reauthorization and Job Creation Act of 2010.

At December 31, 2011, the Company had net operating loss carryforwards of $61.3 million for federal income tax purposes, $73.1 million for foreign income tax purposes and $31.7 million for state income tax purposes to offset future taxable income. The federal net operating loss carryforwards expire through 2030, $66.7 million of the foreign net operating loss carryforwards expire through 2020 with the remaining $6.3 million having an indefinite carry forward period. The state net operating loss carryforwards expire through 2030.

At December 31, 2011 and 2010, several of the Company's subsidiaries had unused net operating loss carryforwards and tax credit carryforwards arising from periods prior to the Company's ownership which expire through 2030. The Internal Revenue Code limits the timing and manner in which the Company may use any acquired net operating losses or tax credits.

Income taxes are not provided on certain undistributed earnings of non-U.S. subsidiaries because such earnings are expected to be indefinitely reinvested and it would not be practicable to determine the amount of the related unrecognized deferred income tax liability. Undistributed earnings of such foreign subsidiaries totaled $168.8 million, $142.2 million and $101.4 million at December 31, 2011, 2010 and 2009, respectively.

The provision for income taxes consisted of the following:


	Years Ended December 31,
	2011			2010		2009
	(In thousands)
Current:
Federal	$	(934	)	$	2,686	$	9,106
State		(1,530	)		1,136		4,021
Foreign		1,813			8,495		8,522

Total current		(651	)		12,317		21,649
Deferred:
Federal		1,078			2,522		1,281
State		2,236			835		(672	)
Foreign		(2,158	)		771		(61	)

Total deferred		1,156			4,128		548

Provision for income taxes	$	505		$	16,445	$	22,197

The income tax effects of significant temporary differences that give rise to deferred tax assets and liabilities, shown before jurisdictional netting, are presented below:


	December 31,
	2011			2010
	(In thousands)
Current assets:
Doubtful accounts	$	1,822		$	2,033
Inventory reserves		24,695			25,131
Tax credits		2,865			1,469
Accrued vacation		2,163			2,082
Accrued bonus		2,330			3,126
Other		3,132			5,088

Total current deferred tax assets		37,007			38,929
Less valuation allowance		(702	)		(852	)

Current deferred tax assets after valuation allowance	$	36,305		$	38,077

Current liabilities:
Other		(179	)		(3,872	)

Total current deferred tax liabilities	$	(179	)	$	(3,872	)

Net current deferred tax assets	$	36,126		$	34,205


	December 31,
	2011			2010
	(In thousands)
Non-current assets:
Benefits and compensation	$	8,991		$	9,616
Stock compensation		28,659			19,770
Deferred revenue		148			389
Net operating loss carryforwards		48,251			35,223
Financing costs		1,472			4,493
Federal & state tax credits		1,333			1,705
Other		—			2,801

Total non-current deferred tax assets		88,854			73,997
Less valuation allowance		(31,602	)		(35,782	)

Non-current deferred tax assets after valuation allowance	$	57,252		$	38,215

Non-current liabilities:
Intangible & fixed assets		(43,152	)		(31,751	)
Deferred gain		(548	)		(449	)
Non-cash interest amortization		(1,847	)		(4,713	)
Other		(191	)		(4,053	)

Total non current deferred tax liabilities	$	(45,738	)	$	(40,966	)

Net non-current deferred tax assets/(liabilities)	$	11,514		$	(2,751	)

Total net deferred tax assets/(liabilities)	$	47,640		$	31,454

A valuation allowance of $32.3 million, $36.6 million and $36.1 million is recorded against the Company's gross deferred tax assets of $125.9 million, $112.9 million and $114.0 million recorded at December 31, 2011, 2010 and 2009, respectively. This valuation allowance relates to deferred tax assets for certain items that will be deductible for income tax purposes under very limited circumstances and for which the Company believes it is not more likely than not that it will realize the associated tax benefit. The Company does not anticipate additional income tax benefits through future reductions in the valuation allowance. However, in the event that the Company determines that it would be able to realize more or less than the recorded amount of net deferred tax assets, an adjustment to the deferred tax asset valuation allowance would be recorded in the period such a determination is made.

The Company's valuation allowance decreased by $4.3 million in 2011 and increased $0.5 million in 2010. The 2011 overall decrease in the valuation allowance was primarily due to tax rate changes in the Netherlands which is offset by a reduction in the related deferred tax asset. Further, the Company recorded an increase to the valuation allowance in Switzerland related to the uncertainty of the future realizability of net operating losses. The 2010 increase in the valuation allowance was primarily related to the uncertainty of the future realizability of net operating losses in Switzerland.

The Company adopted the authoritative guidance on accounting for uncertainty in income taxes on January 1, 2007. A reconciliation of the beginning and ending amount of uncertain tax benefits is as follows:


	2011			2010			2009
	(In thousands)
Balance, beginning of year	$	5,530		$	10,909		$	9,033
Additions for tax positions of prior years		1,001			1,685			3,785
Settlements		(962	)		(5,264	)		—
Lapse of statute		(1,642	)		(1,800	)		(1,909	)

Balance, end of year	$	3,927		$	5,530		$	10,909

Approximately $3.1 million of the balance at December 31, 2011 relates to uncertain tax positions that, if recognized, would affect the annual effective tax rate. Included in the balance of uncertain tax positions at December 31, 2011 is $1.6 million related to tax positions for which it is reasonably possible that the total amounts could significantly change during the twelve months following December 31, 2011, as a result of expiring statutes of limitations.

The Company recognizes interest and penalties relating to uncertain tax positions in income tax expense. The Company recognized a $0.5 million benefit, a $0.9 million benefit, and a $0.5 million expense for interest and penalties in the income statement during the years ended December 31, 2011, 2010 and 2009, respectively. The Company had approximately $1.3 million, $2.1 million, and $3.0 million of interest and penalties accrued at December 31, 2011, 2010 and 2009, respectively.

At December 31, 2009 the Federal income tax returns for the years 2005 through 2007 were under review by the Internal Revenue Service (the "IRS") and the Company had accrued $8.5 million for uncertain tax positions at that time. During 2010, the Company settled the review for the years 2005 through 2007 with the IRS which resulted in $4.0 million in taxes being reclassified from long-term liabilities to current taxes payable and deferred taxes, and $4.5 million being recorded in the consolidated statement of operations as an income tax benefit. This settlement was approved by the IRS Joint Committee on Taxation in December 2011, formally closing the 2005 through 2007 audit. The Company recorded an additional federal income tax benefit of $0.1 million in 2011 as a result of receiving the agreed upon settlement. These amounts include interest and penalties related to the settlement and tax benefit.

The Company files Federal income tax returns, as well as multiple state, local and foreign jurisdiction tax returns. The Company is no longer subject to examinations of its Federal income tax returns by the IRS through fiscal year 2007. All significant state and local matters have been concluded through fiscal 2004. All significant foreign matters have been settled through fiscal 2005.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph h

-Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 136, 172

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 109

-Paragraph 43, 44, 45, 46, 47, 48, 49

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 15

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(h))

-URI http://asc.fasb.org/extlink&oid=6881521&loc=d3e23780-122690

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 740

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319

+ Details

Net Income Per Share

12 Months Ended

Dec. 31, 2011

Net Income Per Share [Abstract]

Net Income Per Share

11.

NET INCOME PER SHARE

In January 2009 the Company adopted the authoritative guidance related to determining whether instruments issued in share-based payment transactions are participating securities. Certain of the Company's unvested restricted share units contain rights to receive nonforfeitable dividends, and thus, are participating securities requiring the two-class method of computing earnings per share. The participating securities had an insignificant impact on the calculation of earnings per share (impacts the rounding by $0.01 or less per share); therefore, the Company does not present the full calculation below.

Amounts used in the calculation of basic and diluted net income per share were as follows:


	Years Ended December 31,
	2011		2010		2009
	(In thousands, except per share amounts)
Basic net income per common share:
Net income	$	27,989	$	65,669	$	50,955
Weighted average common shares outstanding		28,952		29,548		29,038
Basic net income per common share	$	0.97	$	2.21	$	1.75
Diluted net income per common share:
Net income	$	27,989	$	65,669	$	50,955
Weighted average common shares outstanding — Basic		28,952		29,548		29,038
Effect of dilutive securities:
Stock options and restricted stock		543		601		254

Weighted average common shares for diluted earnings per share		29,495		30,149		29,292
Diluted net income per common share	$	0.95	$	2.17	$	1.74

Common stock of approximately 0.3 million, 0.7 million and 2.1 million shares at December 31, 2011, 2010 and 2009, respectively, that are issuable through exercise or conversion of dilutive securities were not included in the computation of diluted net income per share because their effect would have been antidilutive.

Performance Shares and Restricted Units that entitle the holders to approximately 1.8 million shares of common stock are included in the basic and diluted weighted average shares outstanding calculation from their date of issuance because no further consideration is due related to the issuance of the underlying common shares.

- Definition

The entire disclosure for earnings per share.

+ References+ Details

Commitments And Contingencies

12 Months Ended

Dec. 31, 2011

Commitments And Contingencies [Abstract]

Commitment And Contingencies

12.

COMMITMENTS AND CONTINGENCIES

In consideration for certain technology, manufacturing, distribution and selling rights and licenses granted to the Company, the Company has agreed to pay royalties on the sales of products that are commercialized relative to the granted rights and licenses. Royalty payments under these agreements by the Company were not significant for any of the periods presented.

Various lawsuits, claims and proceedings are pending or have been settled by the Company. The most significant of these are described below.

In January 2010, the Company received a notice from the seller's representative of the former Theken companies of a disagreement in the calculation of "trade sales" used in calculating a revenue performance payment that the Company made in November 2009 related to the first performance year that ended September 30, 2009. The notice alleged that the Company owed an additional $6.7 million, and the Company recorded an accrual of $3.4 million for the settlement at that time. There were no amounts due under the unit purchase agreement for the second performance year that ended September 30, 2010. In January 2011, the Company received a notice from the seller's representative that the alleged amount owed had been reduced to $5.7 million. In June 2011 the Company and the seller agreed to settle the matter for $4.6 million, which was accrued at that time, and was paid in August 2011.

The Company has various product liability claims pending against it. During 2011, the most significant of these matters was settled for approximately $4.6 million. The matter was covered by insurance policies and the Company had recorded a corresponding receivable; therefore, there was no net impact on the Company's consolidated statements of operations.

In addition to these matters, we are subject to various claims, lawsuits and proceedings in the ordinary course of the Company's business, including claims by current or former employees, distributors and competitors and with respect to its products. In the opinion of management, such claims are either adequately covered by insurance or otherwise indemnified, or are not expected, individually or in the aggregate, to result in a material adverse effect on our financial condition. However, it is possible that the Company's results of operations, financial position and cash flows in a particular period could be materially affected by these contingencies.

The Company accrues for loss contingencies when it is deemed probable that a loss has been incurred and that loss is estimable. The amounts accrued are based on the full amount of the estimated loss before considering insurance proceeds, and do not include an estimate for legal fees expected to be incurred in connection with the loss contingency. The Company consistently accrues legal fees expected to be incurred in connection with loss contingencies as those fees are incurred by outside counsel as a period cost.

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

Segment And Geographic Information

12 Months Ended

Dec. 31, 2011

Segment And Geographic Information [Abstract]

Segment And Geographic Information

13.

SEGMENT AND GEOGRAPHIC INFORMATION

The Company's chief operating decision maker reviews financial results and manages the business on an aggregate basis. Therefore, financial results are reported in a single operating segment, the development, manufacture and marketing of medical devices.

Revenue consisted of the following:


	Years Ended December 31,
	2011		2010		2009
	(In thousands)
Orthopedics	$	328,782	$	290,050	$	262,170
Neurosurgery		285,341		275,046		256,544
Instruments		165,955		166,972		163,773

Total revenue, net	$	780,078	$	732,068	$	682,487

The Company attributes revenue to geographic areas based on the location of the customer. Total revenue, net and long-lived assets (tangible) by major geographic area are summarized below:


	United States*		Europe		Asia Pacific		Other Foreign**		Consolidated
	(In thousands)
Total revenue, net:
2011	$	593,036	$	94,772	$	44,445	$	47,825	$	780,078
2010		561,240		89,381		40,584		40,863		732,068
2009		519,203		93,414		32,788		37,082		682,487
Long-lived assets:
December 31, 2011	$	125,880	$	17,274	$	934	$	423	$	144,511
December 31, 2010		94,012		14,142		935		469		109,558

*	Includes long-lived assets in Puerto Rico

**	Represents: Canada, Latin America, Africa and the Middle East

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8380-108599

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 12

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8595-108599

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 32

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8933-108599

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 33

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8971-108599

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 26

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8844-108599

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 131

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 34

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8981-108599

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 35

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8984-108599

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 42

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 31

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8924-108599

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 10

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8538-108599

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 30

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 41

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 29

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e8864-108599

+ Details

Selected Quarterly Information

12 Months Ended

Dec. 31, 2011

Selected Quarterly Information [Abstract]

Selected Quarterly Information

14.

SELECTED QUARTERLY INFORMATION — UNAUDITED


	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
	(In thousands, except per share data)
Total revenue, net:
2011	$	181,041	$	193,329	$	202,185	$	203,523
2010		172,698		178,595		186,641		194,134
Gross margin:
2011	$	116,120	$	120,491	$	123,534	$	120,783
2010		109,474		114,131		117,447		122,828
Net income (loss):
2011	$	11,487	$	699	$	11,243	$	4,560
2010		15,222		15,157		16,483		18,807
Basic net income (loss) per common share(1)(2):
2011	$	0.39	$	0.02	$	0.39	$	0.16
2010		0.51		0.51		0.56		0.64
Diluted net income (loss) per common share(1)(2):
2011	$	0.38	$	0.02	$	0.39	$	0.16
2010		0.50		0.50		0.55		0.63

(1)

Per common share amounts for the quarters and full years have been calculated separately. Accordingly, quarterly amounts do not necessarily add to the annual amount because of differences in the weighted average common shares outstanding during each period principally due to the effect of the Company's issuing shares of its common stock during the year.

(2)

Certain of the Company's unvested restricted share units contain rights to receive nonforfeitable dividends, and thus, are participating securities requiring the two-class method of computing earnings per share. The participating securities had an insignificant impact on the calculation of earnings per share (impacts the rounding by less than $0.01 per share) on all of the periods presented; therefore, the Company does not present the full calculation.

The Company recorded an incremental stock based compensation charge during the second quarter of 2011 of $8.4 million related to the renewal of its former chief executive officer's employment agreement. The Company recorded an incremental stock based compensation charge during the fourth quarter of 2011 of $4.9 million related to the accelerated vesting of stock awards for its former chief executive officer upon the appointment of the new chief executive officer and the minimum annual equity award for 2011 for the former chief executive officer, which was fully vested on the date of grant.

The Company incurred incremental costs related to the implementation of its global enterprise resource planning system in the first, second, third, and fourth quarters of 2011 of $2.5 million, $2.4 million, $5.1 million and $3.6 million, respectively, compared to comparable periods in the prior year.

The Company incurred costs related to the remediation of an FDA warning letter and the related underutilization at its Plainsboro, New Jersey manufacturing facility of $1.7 million and $4.0 million, in the third and fourth quarters of 2011, respectively.

During the second and fourth quarters of 2011, the Company identified and recorded certain corrections related to income taxes which related to prior years. Because these changes are not material to the current or previous years, they have been recorded in the second and fourth quarters of 2011. The impact of recording these adjustments resulted in a decrease in net income of $1.7 million in the second quarter of 2011, and an increase in net income of $2.2 million in the fourth quarter of 2011.

- Definition

The entire disclosure for the quarterly financial data in the annual financial statements. The disclosure may include a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income or loss before extraordinary items and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished.

+ References+ Details

Schedule II - Valuation And Qualifying Accounts

12 Months Ended

Dec. 31, 2011

Schedule II - Valuation And Qualifying Accounts [Abstract]

Schedule II - Valuation And Qualifying Accounts

SCHEDULE II — VALUATION AND QUALIFYING ACCOUNTS


Description	Balance at Beginning of Period		Charged to Costs and Expenses			Charged to Other Accounts(1)			Deductions			Balance at End of Period
	(In thousands)
Year ended December 31, 2011:
Allowance for doubtful accounts and sales returns and allowances		$ 7,322		$ 1,118			$ —			$(1,462	)		$ 6,978
Deferred tax asset valuation allowance		36,634		(4,111	)		—			(219	)		32,304
Year ended December 31, 2010:
Allowance for doubtful accounts and sales returns and allowances		$11,216		$(2,167	)		$ —			$(1,727	)		$ 7,322
Deferred tax asset valuation allowance		36,131		431			1,160			(1,088	)		36,634
Year ended December 31, 2009:
Allowance for doubtful accounts and sales returns and allowances		$10,052		$ 2,645			$ —			$(1,481	)		$11,216
Deferred tax asset valuation allowance		35,968		3,649			(3,286	)		(200	)		36,131

(1)

In 2010, $1.2 million of deferred tax liability was reclassified to the valuation allowance with no impact to the consolidated statement of operations. In 2009, the balance was reduced by $3.3 million, which was no longer required as a result of the estimated expiration of the carryforward period of a net operating loss carryforward for which a deferred tax asset had been previously recorded.

Summary Of Significant Accounting Policies (Policy)

12 Months Ended

Dec. 31, 2011

Summary Of Significant Accounting Policies [Abstract]

Basis Of Presentation

BASIS OF PRESENTATION

Principles Of Consolidation

PRINCIPLES OF CONSOLIDATION

Use Of Estimates

USE OF ESTIMATES

Reclassifications

RECLASSIFICATIONS

Certain amounts from the prior years' financial statements have been reclassified in order to conform to the current year's presentation.

Cash And Cash Equivalents

CASH AND CASH EQUIVALENTS

The Company considers all short term, highly liquid investments purchased with original maturities of three months or less to be cash equivalents.

Trade Accounts Receivable And Allowances For Doubtful Accounts Receivable

TRADE ACCOUNTS RECEIVABLE AND ALLOWANCES FOR DOUBTFUL ACCOUNTS RECEIVABLE

Inventories

INVENTORIES


	December 31,
	2011		2010
	(In thousands)
Finished goods	$	106,972	$	87,508
Work in process		36,070		31,536
Raw materials		28,219		27,884

Total inventories, net	$	171,261	$	146,928

Property, Plant And Equipment

PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment balances and corresponding lives were as follows:


	December 31,						Useful Lives
	2011			2010			Useful Lives
	(In thousands)
Land	$	2,709		$	2,726
Buildings and building improvements		7,376			6,964			5-40 years
Leasehold improvements		38,030			38,102			1-20 years
Machinery and production equipment		98,731			96,692			3-20 years
Furniture, fixtures, office equipment and information systems		52,363			45,406			1-15 years
Construction-in-progress		52,965			20,137

Total		252,174			210,027
Less: Accumulated depreciation		(120,791	)		(110,571	)

Property, plant and equipment, net	$	131,383		$	99,456

Depreciation expense associated with property, plant and equipment was $25.5 million, $21.3 million and $18.8 million for the years ended December 31, 2011, 2010 and 2009, respectively.

Goodwill And Other Intangible Assets

GOODWILL AND OTHER INTANGIBLE ASSETS

Changes in the carrying amount of goodwill in 2011 and 2010 were as follows:


	2011			2010
	(In thousands)
Goodwill	$	261,928		$	261,941
Accumulated impairment losses		—			—

Goodwill, beginning of year		261,928			261,941
Ascension Orthopedics, Inc. acquisition		15,909			—
SeaSpine Inc. acquisition		14,283			—
Integra Spine acquisition, earnout payment		1,200			3,400
Welch Allyn, Inc. acquisition		—			601
Integra Neurosciences Pty Ltd., earnout payment		1,059			1,016
Foreign currency translation and other		(1,399	)		(5,030	)

Goodwill, end of year	$	292,980		$	261,928

The components of the Company's identifiable intangible assets were as follows:


	December 31, 2011									December 31, 2010
	Weighted Average Life		Cost		Accumulated Amortization			Net		Weighted Average Life		Cost		Accumulated Amortization			Net
			(Dollars in thousands)									(Dollars in thousands)
Completed technology		11 years	$	75,990	$	(32,157	)	$	43,833		12 years	$	69,261	$	(28,062	)	$	41,199
Customer relationships		11 years		147,230		(57,348	)		89,882		12 years		99,290		(45,505	)		53,785
Trade names		32 years		33,669		(10,897	)		22,772		35 years		33,448		(8,467	)		24,981
Trade names		Indefinite		48,484		—			48,484		Indefinite		49,384		—			49,384
Supplier relationships		26 years		33,810		(5,389	)		28,421		30 years		29,300		(4,525	)		24,775
All other(1)		6 years		11,434		(7,704	)		3,730		15 years		8,440		(7,660	)		780

			$	350,617	$	(113,495	)	$	237,122			$	289,123	$	(94,219	)	$	194,904

(1)

Long-Lived Assets

LONG-LIVED ASSETS

Integra Foundation

INTEGRA FOUNDATION

Derivatives

DERIVATIVES

Foreign Currency

FOREIGN CURRENCY

Income Taxes

INCOME TAXES

Revenue Recognition

REVENUE RECOGNITION

Shipping And Handling Fees And Costs

SHIPPING AND HANDLING FEES AND COSTS

Product Warranties

PRODUCT WARRANTIES

Accrued warranty expense consisted of the following:


	December 31,
	2011			2010
	(In thousands)
Beginning balance	$	548		$	632
Net change		(108	)		(84	)

Ending balance	$	440		$	548

Research And Development

RESEARCH AND DEVELOPMENT

Employee Termination Benefits And Other Exit-Related Costs

EMPLOYEE TERMINATION BENEFITS AND OTHER EXIT-RELATED COSTS

Stock-Based Compensation

STOCK-BASED COMPENSATION

Pension Benefits

PENSION BENEFITS

Concentration Of Credit Risk

CONCENTRATION OF CREDIT RISK

Supplemental Cash Flow Information

SUPPLEMENTAL CASH FLOW INFORMATION

Summary Of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2011

Summary Of Significant Accounting Policies [Abstract]

Schedule Of Inventories, Net


	December 31,
	2011		2010
	(In thousands)
Finished goods	$	106,972	$	87,508
Work in process		36,070		31,536
Raw materials		28,219		27,884

Total inventories, net	$	171,261	$	146,928

Schedule Of Property, Plant And Equipment Balances And Corresponding Lives


	December 31,						Useful Lives
	2011			2010			Useful Lives
	(In thousands)
Land	$	2,709		$	2,726
Buildings and building improvements		7,376			6,964			5-40 years
Leasehold improvements		38,030			38,102			1-20 years
Machinery and production equipment		98,731			96,692			3-20 years
Furniture, fixtures, office equipment and information systems		52,363			45,406			1-15 years
Construction-in-progress		52,965			20,137

Total		252,174			210,027
Less: Accumulated depreciation		(120,791	)		(110,571	)

Property, plant and equipment, net	$	131,383		$	99,456

Schedule Of Changes In Carrying Amount Of Goodwill


	2011			2010
	(In thousands)
Goodwill	$	261,928		$	261,941
Accumulated impairment losses		—			—

Goodwill, beginning of year		261,928			261,941
Ascension Orthopedics, Inc. acquisition		15,909			—
SeaSpine Inc. acquisition		14,283			—
Integra Spine acquisition, earnout payment		1,200			3,400
Welch Allyn, Inc. acquisition		—			601
Integra Neurosciences Pty Ltd., earnout payment		1,059			1,016
Foreign currency translation and other		(1,399	)		(5,030	)

Goodwill, end of year	$	292,980		$	261,928

Components Of Company's Identifiable Intangible Assets


	December 31, 2011									December 31, 2010
	Weighted Average Life		Cost		Accumulated Amortization			Net		Weighted Average Life		Cost		Accumulated Amortization			Net
			(Dollars in thousands)									(Dollars in thousands)
Completed technology		11 years	$	75,990	$	(32,157	)	$	43,833		12 years	$	69,261	$	(28,062	)	$	41,199
Customer relationships		11 years		147,230		(57,348	)		89,882		12 years		99,290		(45,505	)		53,785
Trade names		32 years		33,669		(10,897	)		22,772		35 years		33,448		(8,467	)		24,981
Trade names		Indefinite		48,484		—			48,484		Indefinite		49,384		—			49,384
Supplier relationships		26 years		33,810		(5,389	)		28,421		30 years		29,300		(4,525	)		24,775
All other(1)		6 years		11,434		(7,704	)		3,730		15 years		8,440		(7,660	)		780

			$	350,617	$	(113,495	)	$	237,122			$	289,123	$	(94,219	)	$	194,904

Schedule Of Product Warranties


	December 31,
	2011			2010
	(In thousands)
Beginning balance	$	548		$	632
Net change		(108	)		(84	)

Ending balance	$	440		$	548

- Definition

Tabular disclosure of the useful life and salvage value of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.

+ References+ Details

- Definition

Tabular disclosure of goodwill by reportable segment and in total. Disclosure details may include, but are not limited to, the carrying amount of goodwill, goodwill acquired during the year, goodwill impairment losses recognized, goodwill written-off due to the sale of a business unit, goodwill not yet allocated, and any other changes to goodwill.

+ References+ Details

Acquisitions (Tables)

12 Months Ended

Dec. 31, 2011

Acquisitions [Line Items]

Pro Forma Financial Information, Summary Of Results Of Operations


	Year Ended December 31,
	2011		2010
	(In thousands, except per share amounts)
Total Revenue	$	811,933	$	800,476
Net income	$	23,236	$	51,818
Net income per share:
Basic	$	0.80	$	1.75
Diluted	$	0.79	$	1.71

Welch Allyn [Member]

Acquisitions [Line Items]

Final Purchase Price Of Net Assets Acquired


	Final Purchase Price Allocation
	(Dollars in thousands)
Accounts receivable	$	518
Inventory		138
Property, plant and equipment		280
Intangible assets			Wtd. Avg. Life:
Customer relationships		490	15 years
Technology		263	6 years
In-Process research and development		312	Indefinite
Goodwill		601

Total net assets acquired	$	2,602

Ascension Orthopedics, Inc. Acquisition [Member]

Acquisitions [Line Items]

Schedule Of Purchase Price Allocation


	Preliminary Purchase Price Allocation
	(Dollars in thousands)
Cash	$	627
Inventory		12,760
Accounts receivable		2,917
Other current assets		2,398
Property, plant and equipment		4,649
Other long-term assets		70
Deferred tax asset — long term		12,543
Intangible assets:			Wtd. Avg. Life:
Technology		7,885	10 years
Customer relationships		5,750	12 years
In-process research and development		1,739	Indefinite
Supplier relationship		4,510	10 years
Trade name		560	1 year
Goodwill		15,909

Total assets acquired		72,317
Accounts payable and other liabilities		5,827

Net assets acquired	$	66,490

SeaSpine Inc. Acquisition [Member]

Acquisitions [Line Items]

Schedule Of Purchase Price Allocation


	Preliminary Purchase Price Allocation
	(Dollars in thousands)
Cash	$	201
Inventory		14,900
Accounts receivable		7,608
Other current assets		623
Property, plant and equipment		9,177
Deferred tax asset — long term		302
Intangible assets:			Wtd. Avg. Life:
Technology		3,000	8 years
Customer relationships		41,200	13 years
Non-compete agreements		1,900	4 years
Trade name		300	1 year
Goodwill		14,283

Total assets acquired		93,494
Accounts payable and other liabilities		5,108

Net assets acquired	$	88,386

Culley [Member]

Acquisitions [Line Items]

Final Purchase Price Of Net Assets Acquired


	Final Purchase Price Allocation
	(Dollars in thousands)
Inventory	$	878
Property, plant and equipment		319
Intangible assets — Customer relationships		373	Wtd. Avg. Life –12 years

Total net assets acquired	$	1,570

- Definition

Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.

+ References+ Details

- Definition

Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 51

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141

-Paragraph 52

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Appendix F

-Paragraph F4

-Subparagraph e

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1392-128463

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6909870&loc=d3e1486-128463

+ Details

Debt (Tables)

9 Months Ended

Sep. 30, 2011

Debt [Abstract]

Components Of Interest Expense


	Year Ended December 31,
	2011		2010		2009
	(In thousands)
2016 Notes:
Non-cash interest	$	3,740	$	—	$	—
Cash Interest		2,024		—		—

Total	$	5,764	$	—	$	—


2012 Notes:
Non-cash interest	$	6,850	$	6,401	$	5,981
Cash Interest		3,919		3,919		3,919

Total	$	10,769	$	10,320	$	9,900


2010 Notes:
Non-cash interest	$	—	$	1,190	$	4,456
Cash Interest		—		830		3,587

Total	$	—	$	2,020	$	8,043

Derivative Instruments (Tables)

12 Months Ended

Dec. 31, 2011

Derivative Instruments [Abstract]

Summary Of Fair Value In Balance Sheet For Derivatives Designated As Hedging Instruments


	Fair Value as of				Notional Amount as of
Location on Balance Sheet (a):	December 31, 2011		December 31, 2010		December 31, 2011		December 31, 2010
	(In thousands)
Derivatives designated as hedges — Assets:
Interest rate swap — Other assets(b)	$	—	$	1,825

Derivatives designated as hedges — Liabilities:
Interest rate swap — Accrued expenses and other current liabilities(b)	$	1,634	$	2,095
Foreign currency foward contracts — Accrued expenses and other current liabilities		108		—	$	1,597	$	—
Interest rate swap — Other liabilities(b)		2,458		—

Total Derivatives designated as hedges — Liabilities	$	4,200	$	2,095

Effect Of Derivative Instruments Designated As Cash Flow Hedges On Statements Of Operations


	Amount of Gain (Loss) Recognized in AOCI (Effective Portion)			Amount of Gain (Loss) Reclassified from AOCI Into Earnings (Effective Portion)			Location in Statements of Operations
	(In thousands)
Year Ended December 31, 2011
Foreign currency forward contracts	$	(216	)	$	—		Cost of product revenue
Interest rate swap		(6,090	)		(2,269	)	Interest (expense)

	$	(6,306	)	$	(2,269	)

Year Ended December 31, 2010
Foreign currency forward contracts	$	2,756		$	2,782		Other income (expense)
Interest rate swap		(270	)		—		Interest (expense)

	$	2,486		$	2,782

- Definition

Tabular disclosure of the location and amount of gains and losses reported in the statement of financial performance, or when applicable, the statement of financial position. For example, (a) gains and losses recognized in the income statement on derivative instruments designated and qualifying as hedging instruments in fair value hedges and related hedged items designated and qualifying in fair value hedges and (b) gains and losses initially recognized in other comprehensive income on derivative instruments designated and qualifying as cash flow hedges.

+ References+ Details

- Definition

Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.

+ References+ Details

Treasury Stock (Tables)

12 Months Ended

Dec. 31, 2011

Treasury Stock [Abstract]

Schedule Of Treasury Stock Activity


	Years Ended December 31,
	2011				2010
	$		# of Shares		$		# of Shares
	(In thousands)
Shares repurchased in the open market in connection with the 2008 Authorization	$	—		—	$	31,278		858
Shares repurchased in the open market in connection with the 2010 Authorization		45,893		1,104		—		—
Shares repurchased in connection with the issuance of the 2016 Notes		37,570		805		—		—

Total	$	83,463		1,909	$	31,278		858

- Definition

Tabular disclosure of an entity's treasury stock, including the average cost per share, carrying basis for each class of treasury stock, description of share repurchase program authorized by an entity's board of directors, the number of shares repurchased, the cost of the shares repurchased, the remaining maximum dollar value of shares available for repurchase under the program, the treatment of the purchase price in excess of the current market value, number of shares held for each class of treasury stock, and other information necessary to a fair presentation.

+ References+ Details

Stock Purchase And Award Plans (Tables)

12 Months Ended

Dec. 31, 2011

Stock Purchase And Award Plans [Abstract]

Summary Of Employee Stock-Based Compensation Expense


	Years Ended December 31,
	2011		2010		2009
	(In thousands)
Selling, general and administrative	$	26,310	$	16,694	$	14,958
Research and development expense		404		426		492
Cost of product revenues		91		89		130

Total employee stock-based compensation expense		26,805		17,209		15,580
Total tax benefit related to employee stock-based compensation expense		10,468		7,006		6,253

Net effect on net income	$	16,337	$	10,203	$	9,327

Summary Of Weighted-Average Assumptions


	Years Ended December 31,
	2011	2010	2009
Dividend yield	0%	0%	0%
Expected volatility	28%	30%	29%
Risk free interest rate	2.47%	2.82%	2.0%
Expected life of option from grant date	8 years	8 years	8 years

Summary Of Stock Option Activity


Stock Options	Shares			Weighted Average Exercise Price		Weighted Average Contractual Term in Years		Aggregate Intrinsic Value
	(In thousands)							(In thousands)
Outstanding at December 31, 2010		1,560			$38.13
Granted		34			50.78
Exercised		(100	)		34.43
Forfeited or Expired		(11	)		36.60

Outstanding at December 31, 2011		1,483			$38.68		4.4		$270

Vested or expected to vest at December 31, 2011		1,483			$38.68		4.4		$270

Exercisable at December 31, 2011		1,465			$38.54		4.4		$270

Summary Of Vested And Unvested RSU


	Restricted Stock Awards					Performance Stock and Contract Stock Awards
	Shares			Wtd. Avg. Grant Date Fair Value Per Share		Shares			Wtd. Avg Grant Date Fair Value Per Share
	(In thousands)			(In thousands)
Unvested, December 31, 2010		413			$34.98		277			$40.74
Granted		122			47.48		361			40.29
Cancellations		(35	)		37.99		(6	)		40.66
Released		(195	)		36.95		(9	)		44.51
Vested but not released		—			—		(479	)		43.83

Unvested, December 31, 2011		305			$38.37		144			$29.15

Retirement Benefit Plans (Tables)

12 Months Ended

Dec. 31, 2011

Retirement Benefit Plans [Abstract]

Net Periodic Benefit Costs For Defined Benefit Pension Plans


	Years Ended December 31,
	2011			2010			2009
	Non U.S. Plans			Non U.S. Plans			Non U.S. Plans
	(In thousands)
Service cost	$	26		$	93		$	121
Interest cost		650			645			605
Expected return on plan assets		(589	)		(515	)		(413	)
Recognized net actuarial loss		—			86			307

Net periodic benefit cost	$	87		$	309		$	620

Weighted Average Assumptions


	Years Ended December 31,
	2011			2010			2009
	Non U.S. Plans			Non U.S. Plans			Non U.S. Plans
Discount rate		4.7	%		5.4	%		5.9	%
Expected return on plan assets		2.9	%		5.2	%		5.4	%
Rate of compensation increase		—	%		3.4	%		3.7	%

Changes In Projected Benefit Obligation And Fair Value Of Plan Assets


	December 31,
	2011			2010
	Non-U.S. Plans			Non-U.S. Plans
	(In thousands)
CHANGE IN PROJECTED BENEFIT OBLIGATION
Projected benefit obligation, beginning of year	$	12,042		$	11,550
Service cost		26			93
Interest cost		650			645
Participant contributions		5			17
Benefits paid		(688	)		(464	)
Actuarial loss (gain)		610			551
Curtailment gain		(116	)		—
Effect of foreign currency exchange rates		27			(350	)

Projected benefit obligation, end of year	$	12,556		$	12,042

CHANGE IN PLAN ASSETS
Plan assets at fair value, beginning of year	$	10,834		$	9,302
Actual return on plan assets		1,970			1,070
Employer contributions		1,115			1,157
Participant contributions		11			17
Benefits paid		(678	)		(444	)
Effect of foreign currency exchange rates		(26	)		(268	)

Plan assets at fair value, end of year	$	13,226		$	10,834

Schedule Of Reconciliation Of Funded Status



	December 31,
	2011			2010
	Non-U.S. Plans			Non-U.S. Plans
	(In thousands)
RECONCILIATION OF FUNDED STATUS
Funded status, projected benefit obligation in excess of (less than) plan assets	$	670		$	(1,208	)
Unrecognized net actuarial loss		199			1,061
Accumulated other comprehensive loss		(199	)		(1,061	)

Amounts recognized	$	670		$	(1,208	)

Schedule Of Weighted Average Allocation Of Plan Assets


	December 31,
	2011			2010
	Non-U.S. Plans			Non-U.S. Plans
Equity securities		—	%		19	%
Corporate bonds		—	%		33	%
Government bonds		97	%		46	%
Cash		3	%		2	%

		100	%		100	%

Schedule Of Pension Plan Assets At Fair Value


		Fair Value Measurements at December 31, 2011:
Manager/Fund	Asset Category	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
		(In thousands)
Bank account	Cash	$	344		$344		$ —		$—
Legal & General Index-Linked Gilts Index (various tenors)(c)	Index-linked government bonds		11,117		—		11,117		—
Legal & General Over 15 Year Gilts Index(d)	Government bonds		1,765		—		1,765		—

Total		$	13,226		$344		$12,882		$—


		Fair Value Measurements at December 31, 2010:
Manager/Fund	Asset Category	Total		Quoted Prices in Active Markets for Identical Assets (Level 1)		Significant Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
		(In thousands)
Bank account	Cash	$	254		$254		$ —		$—
Baillie Gifford-Managed Pension Fund(a)	Equity securities		2,012		—		2,012		—
	Corporate bonds		134		—		134		—
	Cash		46		46		—		—
Baillie Gifford-Investment Grade Long Bond Fund(b)	Corporate bonds		3,439		—		3,439		—
Legal & General Over 15 Year Index-Linked Gilts Index(c)	Index-linked government bonds		4,949		—		4,949		—

Total		$	10,834		$300		$10,534		$—

(a)	This category represents a pooled fund consisting of holdings in a range of UK and overseas equities and bonds, and cash.

(b)	This category represents a diversified portfolio of investment-grade fixed-interest securities.

(c)	This category represents funds consisting of index-linked gilts and is designated to follow a benchmark index.

(d)	This category represents a fund consisting of gilts and is designed to follow a benchmark index.

Schedule Of Expected Benefit Payments


	Expected Future Benefit Payments
	(In thousands)
2012		$	480
2013			518
2014			549
2015			583
2016			614
2017-2021			3,520

Leases And Related Party Leases (Tables)

12 Months Ended

Dec. 31, 2011

Schedule Of Minimum Lease Payments


	Related Parties		Third Parties		Total
	(In thousands)
2012	$	1,009	$	11,103	$	12,112
2013		1,027		10,157		11,184
2014		1,027		8,780		9,807
2015		974		5,286		6,260
2016		974		2,468		3,442
Thereafter		1,879		3,516		5,395

Total minimum lease payments	$	6,890	$	41,310	$	48,200

- Definition

Tabular disclosure of a lessee's leasing arrangements including: (1) the basis on which contingent rental payments are determined, (2) the existence and terms of renewal or purchase options and escalation clauses, (3) restrictions imposed by lease arrangements, such as those concerning dividends, additional debt, and further leasing, (4) rent holidays, rent concessions, or leasehold improvement incentives and unusual provisions or conditions. Disclosure may also include the specific period used to amortize material leasehold improvements made at the inception of the lease or during the lease term. Additionally, for operating leases having initial or remaining noncancelable lease terms in excess of one year: (a) future minimum rental payments required as of the date of the latest balance sheet presented, in the aggregate and for each of the five succeeding fiscal years, (b) the total of minimum rentals to be received in the future under noncancelable subleases as of the date of the latest balance sheet presented, and (c) for all operating leases, rental expense for each period for which an income statement is presented, with separate amounts for minimum rentals, contingent rentals, and sublease rentals. Rental payments under leases with terms of a month or less that were not renewed need not be included.

+ References+ Details

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2011

Income Taxes [Abstract]

Schedule Of Income Before Income Taxes


	Years Ended December 31,
	2011		2010		2009
	(In thousands)
United States operations	$	1,507	$	37,026	$	40,497
Foreign operations		26,987		45,088		32,655

Total	$	28,494	$	82,114	$	73,152

Schedule Of Effective Income Tax Rate Reconciliation


	Years Ended December 31,
	2011			2010			2009
Federal statutory rate		35.0	%		35.0	%		35.0	%
Increase (reduction) in income taxes resulting from:
State income taxes, net of federal tax benefit		6.0	%		2.6	%		2.6	%
Foreign operations		(18.1	)%		(10.3	)%		(9.9	)%
Incentive stock option expense		—	%		(0.3	)%		(0.2	)%
Change in valuation allowances		(14.0	)%		1.7	%		4.4	%
Uncertain tax positions		(5.8	)%		(4.6	)%		—	%
Other		(1.3	)%		(4.1	)%		(1.6	)%

Effective tax rate		1.8	%		20.0	%		30.3	%

Schedule Of Provision For Income Taxes


	Years Ended December 31,
	2011			2010		2009
	(In thousands)
Current:
Federal	$	(934	)	$	2,686	$	9,106
State		(1,530	)		1,136		4,021
Foreign		1,813			8,495		8,522

Total current		(651	)		12,317		21,649
Deferred:
Federal		1,078			2,522		1,281
State		2,236			835		(672	)
Foreign		(2,158	)		771		(61	)

Total deferred		1,156			4,128		548

Provision for income taxes	$	505		$	16,445	$	22,197

Schedule Of Deferred Tax Assets And Liabilities


	December 31,
	2011			2010
	(In thousands)
Current assets:
Doubtful accounts	$	1,822		$	2,033
Inventory reserves		24,695			25,131
Tax credits		2,865			1,469
Accrued vacation		2,163			2,082
Accrued bonus		2,330			3,126
Other		3,132			5,088

Total current deferred tax assets		37,007			38,929
Less valuation allowance		(702	)		(852	)

Current deferred tax assets after valuation allowance	$	36,305		$	38,077

Current liabilities:
Other		(179	)		(3,872	)

Total current deferred tax liabilities	$	(179	)	$	(3,872	)

Net current deferred tax assets	$	36,126		$	34,205


	December 31,
	2011			2010
	(In thousands)
Non-current assets:
Benefits and compensation	$	8,991		$	9,616
Stock compensation		28,659			19,770
Deferred revenue		148			389
Net operating loss carryforwards		48,251			35,223
Financing costs		1,472			4,493
Federal & state tax credits		1,333			1,705
Other		—			2,801

Total non-current deferred tax assets		88,854			73,997
Less valuation allowance		(31,602	)		(35,782	)

Non-current deferred tax assets after valuation allowance	$	57,252		$	38,215

Non-current liabilities:
Intangible & fixed assets		(43,152	)		(31,751	)
Deferred gain		(548	)		(449	)
Non-cash interest amortization		(1,847	)		(4,713	)
Other		(191	)		(4,053	)

Total non current deferred tax liabilities	$	(45,738	)	$	(40,966	)

Net non-current deferred tax assets/(liabilities)	$	11,514		$	(2,751	)

Total net deferred tax assets/(liabilities)	$	47,640		$	31,454

Schedule of Uncertain Tax Benefits Reconciliation


	2011			2010			2009
	(In thousands)
Balance, beginning of year	$	5,530		$	10,909		$	9,033
Additions for tax positions of prior years		1,001			1,685			3,785
Settlements		(962	)		(5,264	)		—
Lapse of statute		(1,642	)		(1,800	)		(1,909	)

Balance, end of year	$	3,927		$	5,530		$	10,909

Net Income Per Share (Tables)

12 Months Ended

Dec. 31, 2011

Net Income Per Share [Abstract]

Basic And Diluted Net Income Per Share


	Years Ended December 31,
	2011		2010		2009
	(In thousands, except per share amounts)
Basic net income per common share:
Net income	$	27,989	$	65,669	$	50,955
Weighted average common shares outstanding		28,952		29,548		29,038
Basic net income per common share	$	0.97	$	2.21	$	1.75
Diluted net income per common share:
Net income	$	27,989	$	65,669	$	50,955
Weighted average common shares outstanding — Basic		28,952		29,548		29,038
Effect of dilutive securities:
Stock options and restricted stock		543		601		254

Weighted average common shares for diluted earnings per share		29,495		30,149		29,292
Diluted net income per common share	$	0.95	$	2.17	$	1.74

Segment And Geographic Information (Tables)

12 Months Ended

Dec. 31, 2011

Segment And Geographic Information [Abstract]

Revenues By Market Category


	Years Ended December 31,
	2011		2010		2009
	(In thousands)
Orthopedics	$	328,782	$	290,050	$	262,170
Neurosurgery		285,341		275,046		256,544
Instruments		165,955		166,972		163,773

Total revenue, net	$	780,078	$	732,068	$	682,487

Revenue And Long-Lived Assets By Geographic Area


	United States*		Europe		Asia Pacific		Other Foreign**		Consolidated
	(In thousands)
Total revenue, net:
2011	$	593,036	$	94,772	$	44,445	$	47,825	$	780,078
2010		561,240		89,381		40,584		40,863		732,068
2009		519,203		93,414		32,788		37,082		682,487
Long-lived assets:
December 31, 2011	$	125,880	$	17,274	$	934	$	423	$	144,511
December 31, 2010		94,012		14,142		935		469		109,558

*	Includes long-lived assets in Puerto Rico

**	Represents: Canada, Latin America, Africa and the Middle East

- Definition

Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries.

+ References+ Details

Selected Quarterly Information (Tables)

12 Months Ended

Dec. 31, 2011

Selected Quarterly Information [Abstract]

Selected Quarterly Information


	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
	(In thousands, except per share data)
Total revenue, net:
2011	$	181,041	$	193,329	$	202,185	$	203,523
2010		172,698		178,595		186,641		194,134
Gross margin:
2011	$	116,120	$	120,491	$	123,534	$	120,783
2010		109,474		114,131		117,447		122,828
Net income (loss):
2011	$	11,487	$	699	$	11,243	$	4,560
2010		15,222		15,157		16,483		18,807
Basic net income (loss) per common share(1)(2):
2011	$	0.39	$	0.02	$	0.39	$	0.16
2010		0.51		0.51		0.56		0.64
Diluted net income (loss) per common share(1)(2):
2011	$	0.38	$	0.02	$	0.39	$	0.16
2010		0.50		0.50		0.55		0.63

(1)

(2)

Summary Of Significant Accounting Policies (Narrative) (Details) (USD $) In Millions, except Share data, unless otherwise specified	9 Months Ended	12 Months Ended								3 Months Ended	12 Months Ended
	Sep. 30, 2010	Dec. 31, 2011 years	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2009 Trademarks/Brand Names [Member]	Dec. 31, 2009 Innovative Spinal Technologies [Member]	Dec. 31, 2011 Technology [Member]	Dec. 31, 2010 Technology [Member]	Dec. 31, 2009 Technology [Member]	Jun. 30, 2011 Trade Name [Member]	Dec. 31, 2011 Trade Name [Member]	Dec. 31, 2010 Trade Name [Member]	Dec. 31, 2011 Property, Plant and Equipment [Member]	Dec. 31, 2010 Property, Plant and Equipment [Member]	Dec. 31, 2009 Property, Plant and Equipment [Member]	Dec. 31, 2011 Europe [Member]
Summary Of Significant Accounting Policies [Line Items]
Line of Credit Facility converted into a term loan			$ 150.0
Capital Expenditures Incurred but Not yet Paid		6.4	1.1	1.0
Capitalized research and development costs		1.7	0.3
Distribution and handling costs		11.5	9.6	8.3
Charitable contributions		0.3	0.7	0.6
Amortization expense		24.6	17.9	21.0			8.2	5.9	6.6
Annual amortization expense expected to approximate in 2012		25.0
Annual amortization expense expected to approximate in 2013		19.1
Annual amortization expense expected to approximate in 2014		18.1
Annual amortization expense expected to approximate in 2015		16.2
Annual amortization expense expected to approximate in 2016		14.0
Impairment charges					0.6		2.1		0.9	0.9	0.2	0.8
Depreciation													25.5	21.3	18.8
Extended warranties, in years		2
Research and development in process						0.3
Pension Contributions		1.1	1.1	0.4
Accounts receivables from certain European countries customers																5.8
Accounts receivable reserved from certain European countries																0.8
Interest Paid		13.2	8.8	11.3
Income Taxes Paid		14.5	23.4	20.5
Stock options exercised			282,086
Fair market value of shares tendered in lieu of cash	$ 3.1
Number Of Shares Tendered			73,546

Summary Of Significant Accounting Policies (Schedule Of Inventories, Net) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Summary Of Significant Accounting Policies [Abstract]
Finished goods	$ 106,972	$ 87,508
Work-in process	36,070	31,536
Raw materials	28,219	27,884
Inventories, net	$ 171,261	$ 146,928

Summary Of Significant Accounting Policies (Schedule Of Property, Plant And Equipment Balances And Corresponding Lives) (Details) (USD $) In Thousands, unless otherwise specified			12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011 Furniture and Fixtures [Member]	Dec. 31, 2011 Leasehold Improvements [Member]	Dec. 31, 2011 Building and Building Improvements [Member]	Dec. 31, 2011 Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Furniture, fixtures, office equipment and information systems	$ 52,363	$ 45,406
Land	2,709	2,726
Building and building improvements	7,376	6,964
Leasehold improvements	38,030	38,102
Machinery and production equipment	98,731	96,692
Construction in progress	52,965	20,137
Total	252,174	210,027
Less: Accumulated depreciation	(120,791)	(110,571)
Property, Plant and Equipment, Net, Total	$ 131,383	$ 99,456
Property, Plant and Equipment, Useful Life, Maximum			15	20	40	20
Property, Plant and Equipment, Useful Life, Minimum			1	1	5	3

Summary Of Significant Accounting Policies (Schedule Of Changes In Carrying Amount Of Goodwill) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Goodwill And Other Intangible Assets [Line Items]
Goodwill	$ 261,928	$ 261,941
Goodwill at December 31, 2010	261,928	261,941
Foreign currency translation	(1,399)	(5,030)
Goodwill at December 31, 2011	292,980	261,928
Welch Allyn, Inc. [Member]
Goodwill And Other Intangible Assets [Line Items]
Goodwill acquired during the period		601
Ascension Orthopedics, Inc. Acquisition [Member]
Goodwill And Other Intangible Assets [Line Items]
Goodwill acquired during the period	15,909
SeaSpine Inc. Acquisition [Member]
Goodwill And Other Intangible Assets [Line Items]
Goodwill acquired during the period	14,283
Integra Spine Acquisition [Member]
Goodwill And Other Intangible Assets [Line Items]
Goodwill acquired during the period	1,200	3,400
Integra Neurosciences Pty Ltd. [Member]
Goodwill And Other Intangible Assets [Line Items]
Goodwill acquired during the period	$ 1,059	$ 1,016

- Definition

Carrying amount as of the balance sheet date, which is the cumulative amount paid and (if applicable) the fair value of any noncontrolling interest in the acquiree, adjusted for any amortization recognized prior to the adoption of any changes in generally accepted accounting principles (as applicable) and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 43

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 68

-Subparagraph l

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 45

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 350

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6905597&loc=d3e13816-109267

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 72

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 142

-Paragraph 45

-Subparagraph e

-Clause 1

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 141R

-Paragraph 34

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The aggregate amount of goodwill acquired in the period and allocated to the reportable segment. The value is stated at fair value based on the purchase price allocation.

+ References+ Details

Summary Of Significant Accounting Policies (Components Of Company's Identifiable Intangible Assets) (Details) (USD $)

12 Months Ended

Dec. 31, 2011

years

Dec. 31, 2010

years

Goodwill And Other Intangible Assets [Line Items]

Cost

$ 350,617,000

$ 289,123,000

Accumulated Amortization

(113,495,000)

(94,219,000)

Net

237,122,000

194,904,000

Indefinite lived in-process research and development

1,700,000

300,000

Completed Technology [Member]

Goodwill And Other Intangible Assets [Line Items]

Weighted Average Life, Years

Cost

75,990,000

69,261,000

Accumulated Amortization

(32,157,000)

(28,062,000)

Net

43,833,000

41,199,000

Customer Relationship [Member]

Goodwill And Other Intangible Assets [Line Items]

Weighted Average Life, Years

Cost

147,230,000

99,290,000

Accumulated Amortization

(57,348,000)

(45,505,000)

Net

89,882,000

53,785,000

Trademarks/Brand Names [Member]

Goodwill And Other Intangible Assets [Line Items]

Weighted Average Life, Years

Cost

33,669,000

33,448,000

Accumulated Amortization

(10,897,000)

(8,467,000)

Net

22,772,000

24,981,000

Trademarks/Brand Names Indefinite [Member]

Goodwill And Other Intangible Assets [Line Items]

Indefinite-lived intangible assets

48,484,000

49,384,000

Supplier Relationships [Member]

Goodwill And Other Intangible Assets [Line Items]

Weighted Average Life, Years

Cost

33,810,000

29,300,000

Accumulated Amortization

(5,389,000)

(4,525,000)

Net

28,421,000

24,775,000

All Other [Member]

Goodwill And Other Intangible Assets [Line Items]

Weighted Average Life, Years

^[1]

Cost

11,434,000

^[1]

8,440,000

^[1]

Accumulated Amortization

(7,704,000)

^[1]

(7,660,000)

^[1]

Net

3,730,000

^[1]

780,000

^[1]

In-Process Research And Development [Member]

Goodwill And Other Intangible Assets [Line Items]

Indefinite lived in-process research and development

$ 1,700,000

$ 300,000

[1]

Summary Of Significant Accounting Policies (Schedule Of Product Warranties) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Summary Of Significant Accounting Policies [Abstract]
Beginning balance	$ 548	$ 632
Net change	(108)	(84)
Ending balance	$ 440	$ 548

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.

+ References+ Details

Acquisitions (Narrative) (Details) In Millions, unless otherwise specified	1 Months Ended					12 Months Ended								1 Months Ended				20 Months Ended
	Jun. 30, 2011 USD ($)	Nov. 30, 2009 USD ($)	Oct. 31, 2008 USD ($)	Oct. 31, 2008 AUD	Aug. 31, 2008	Dec. 31, 2011 USD ($)	Dec. 31, 2011 AUD	Dec. 31, 2010 USD ($)	Dec. 31, 2010 AUD	May 31, 2010 Welch [Member] USD ($)	Sep. 30, 2010 Culley [Member] USD ($)	Sep. 30, 2010 Culley [Member] AUD	Sep. 23, 2011 Ascension Orthopedics, Inc. Acquisition [Member] USD ($)	Nov. 30, 2009 Integra Neurosciences Pty Ltd. [Member] AUD	Oct. 31, 2008 Integra Neurosciences Pty Ltd. [Member] USD ($)	Oct. 31, 2008 Integra Neurosciences Pty Ltd. [Member] AUD	May 23, 2011 SeaSpine Inc. Acquisition [Member] USD ($)	Jun. 30, 2011 Theken [Member] USD ($)	Aug. 31, 2008 Theken [Member] USD ($)
Acquisitions [Line Items]
Period of revenue performance					2
Term of performance after acquisition, in years			3	3
Company acquired in cash										$ 2.4	$ 1.6	1.7	$ 66.5		$ 4.0	6.0	$ 89.0		$ 75.0
Working capital and indemnification holdback																	7.4
Working capital adjustment reduced the purchase price						0.6
Acquisitions expenses and working capital adjustments															0.3
Maximum future payments based on performance																			125.0
Acquisition expenses																			2.4
Working capital adjustments due to acquisition										0.2									3.9
Year 1 revenue performance obligation		52.0
Business acquisition contingent consideration cash payment		0.9	2.1	3.1		1.0	1.0	1.0	1.0					1.0
Accrued additional for disputed settlement amount	4.6																	4.6
Nonrecurring expenses for acquisition costs						$ 4.3

Acquisitions (Final Purchase Price Of Net Assets Acquired From Ascension) (Details) (Ascension Orthopedics, Inc. Acquisition [Member], USD $) In Thousands, unless otherwise specified	0 Months Ended
	Sep. 23, 2011
Acquisitions [Line Items]
Cash	$ 627
Inventory	12,760
Accounts receivable	2,917
Other current assets	2,398
Property, plant and equipment	4,649
Other long-term assets	70
Deferred tax asset - long term	12,543
In-process research and development	1,739
Goodwill	15,909
Total assets acquired	72,317
Accounts payable and other current liabilities	5,827
Net assets acquired	66,490
Technology [Member]
Acquisitions [Line Items]
Intangible assets	7,885
Weighted average life in years	10
Customer Relationships [Member]
Acquisitions [Line Items]
Intangible assets	5,750
Weighted average life in years	12
Supplier Relationship [Member]
Acquisitions [Line Items]
Intangible assets	4,510
Weighted average life in years	10
Trade Name [Member]
Acquisitions [Line Items]
Intangible assets	$ 560
Weighted average life in years	1

Acquisitions (Final Purchase Price Of Net Assets Acquired From SeaSpine) (Details) (SeaSpine Inc. Acquisition [Member], USD $) In Thousands, unless otherwise specified	0 Months Ended
	May 23, 2011
Acquisitions [Line Items]
Cash	$ 201
Inventory	14,900
Accounts receivable	7,608
Other current assets	623
Property, plant and equipment	9,177
Deferred tax asset - long term	302
Goodwill	14,283
Total assets acquired	93,494
Accounts payable and other current liabilities	5,108
Net assets acquired	88,386
Technology [Member]
Acquisitions [Line Items]
Intangible assets	3,000
Weighted average life in years	8
Customer Relationships [Member]
Acquisitions [Line Items]
Intangible assets	41,200
Weighted average life in years	13
Non-Compete Agreements [Member]
Acquisitions [Line Items]
Intangible assets	1,900
Weighted average life in years	4
Trade Name [Member]
Acquisitions [Line Items]
Intangible assets	$ 300
Weighted average life in years	1

Acquisitions (Final Purchase Price Of Net Assets Acquired From Culley) (Details) (Culley [Member], USD $) In Thousands, unless otherwise specified	1 Months Ended
	Sep. 30, 2010
Acquisitions [Line Items]
Inventory	$ 878
Property, plant and equipment	319
Total assets acquired	1,570
Customer Relationships [Member]
Acquisitions [Line Items]
Intangible assets	$ 373
Weighted average life in years	12

Acquisitions (Final Purchase Price Of Net Assets Acquired From Welch) (Details) (Welch [Member], USD $) In Thousands, unless otherwise specified	1 Months Ended
	May 31, 2010
Acquisitions [Line Items]
Inventory	$ 138
Accounts receivable	518
Property, plant and equipment	280
In-process research and development	312
Goodwill	601
Total assets acquired	2,602
Technology [Member]
Acquisitions [Line Items]
Intangible assets	263
Weighted average life in years	6
Customer Relationships [Member]
Acquisitions [Line Items]
Intangible assets	$ 490
Weighted average life in years	15

Acquisitions (Pro Forma Financial Information, Summary Of Results Of Operations) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Acquisitions [Abstract]
Total Revenue	$ 811,933	$ 800,476
Net income	$ 23,236	$ 51,818
Net income per share, Basic	$ 0.80	$ 1.75
Net income per share, Diluted	$ 0.79	$ 1.71

- Definition

The pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.

+ References+ Details

- Definition

The pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.

+ References+ Details

Debt (Narrative) (Details) (USD $) Share data in Millions, except Per Share data, unless otherwise specified	12 Months Ended			9 Months Ended	12 Months Ended		0 Months Ended	3 Months Ended				12 Months Ended		0 Months Ended	9 Months Ended	12 Months Ended		0 Months Ended	9 Months Ended	12 Months Ended						12 Months Ended		12 Months Ended
	Dec. 31, 2011	Dec. 31, 2009	Dec. 31, 2010	Sep. 30, 2011 Senior Credit Facility [Member]	Dec. 31, 2011 Senior Credit Facility [Member]	Dec. 31, 2010 Term Loan December 31, 2010 [Member]	Jun. 11, 2007 2010 Senior Convertible Notes [Member]	Dec. 31, 2009 2010 Senior Convertible Notes [Member]	Sep. 30, 2009 2010 Senior Convertible Notes [Member]	Jun. 30, 2009 2010 Senior Convertible Notes [Member]	Mar. 31, 2009 2010 Senior Convertible Notes [Member]	Dec. 31, 2009 2010 Senior Convertible Notes [Member]	Dec. 31, 2011 2010 Senior Convertible Notes [Member]	Jun. 11, 2007 2012 Senior Convertible Notes [Member]	Sep. 30, 2011 2012 Senior Convertible Notes [Member]	Dec. 31, 2011 2012 Senior Convertible Notes [Member]	Dec. 31, 2010 2012 Senior Convertible Notes [Member]	Jun. 15, 2011 2016 Senior Convertible Notes [Member]	Sep. 30, 2011 2016 Senior Convertible Notes [Member]	Dec. 31, 2011 2016 Senior Convertible Notes [Member]	Dec. 31, 2011 Revolving Credit Component [Member]	Dec. 31, 2010 Revolving Credit Component [Member]	Sep. 30, 2011 Option ii [Member] Option X [Member]	Sep. 30, 2011 Option ii [Member] Option Y [Member] Senior Credit Facility [Member]	Sep. 30, 2011 Option ii [Member] Option Z [Member]	Dec. 31, 2011 August 2010 Amendment [Member]	Dec. 31, 2010 August 2010 Amendment [Member] Senior Credit Facility [Member]	Dec. 31, 2011 August 2010 Amendment [Member] Senior Credit Facility [Member] Minimum [Member]	Dec. 31, 2011 August 2010 Amendment [Member] Senior Credit Facility [Member] Maximum [Member]	Dec. 31, 2011 June 2011 Amendment [Member]	Dec. 31, 2011 June 2011 Amendment [Member] Senior Credit Facility [Member] Minimum [Member]	Dec. 31, 2011 June 2011 Amendment [Member] Senior Credit Facility [Member] Maximum [Member]
Debt Instrument [Line Items]
Principal amount outstanding								$ 77,900,000				$ 77,900,000		$ 165,000,000		$ 165,000,000	$ 165,000,000	$ 230,000,000		$ 230,000,000
Line of credit facility outstanding																					179,700,000	100,000,000
Interest rate on debt						2.60%	2.75%							2.375%				1.625%
Portion of the debt proceeds that was classified as equity at the time of the offering							16,400,000							30,600,000				43,200,000
Effective interest rate implicit in the liability component							6.50%							6.80%				5.60%
Financing fees					1,300,000													6,300,000
Carrying amount of liability	352,576,000		155,154,000													162,000,000	155,200,000			190,600,000
Debt extinguishment liability component								78,000,000				78,000,000
Unamortized discount																3,000,000	9,800,000			39,400,000
Senior credit facility size increased to																											450,000,000			600,000,000
Reallocated term loan					150,000,000
Available borrowings under senior secured revolving credit facility					420,300,000
Line of Credit Facility, expiration date																										August 10, 2015				June 8, 2016
Interest rates available to the Company at its option																												1.75%	2.50%		1.00%	1.75%
Interest rates descriptions																							the weighted average overnight Federal funds rate, as published by the Federal Reserve Bank of New York, plus 0.5%	the prime lending rate of Bank of America, N.A.	the one-month Eurodollar Rate plus 1.0%
Consolidated funded indebtedness					40,000,000
Additional commitments					200,000,000
Line of credit, collateral				substantially all of the assets of the Company's U.S. subsidiaries, excluding intangible assets.
Line of credit, covenant terms				The Senior Credit Facility is subject to various financial and negative covenants
Line of credit, commitment fee percentage																												0.15%	0.30%		0.20%	0.50%
Weighted average interest rate on debt																					2.00%	2.50%
Fair value of outstanding borrowings					162,200,000											163,800,000				204,400,000
Principal amount outstanding						148,100,000
Principal amount to be considered for conversion purpose															1,000					1,000
Initial conversion price															$ 64.96					$ 57.44
Number of shares to potentially buy back under the call option																		4.0
Number of shares available to hedge participants																				4.0
The earliest expiration date of the warrants																		March 15, 2017
Latest expiration of warrants, trading days																		100
Earliest conversion date	June 15, 2016
Debt instrument, maturity date																			Dec. 15, 2016
Debt instrument, call and warrant transactions descriptions																			In connection with the issuance of the 2016 Notes, the Company entered into call transactions and warrant transactions, primarily with affiliates of the initial purchasers of such notes (the "hedge participants"). The cost of the call transactions to the Company was approximately $42.9 million, representing options to buy 4.0 million shares from the hedge participants at an initial strike price of $57.44 per share, subject to customary anti-dilution adjustments. These transactions are expected to reduce the potential dilution upon conversion of the 2016 Notes. The Company received approximately $28.5 million of proceeds from the warrant transactions, representing an obligation to potentially deliver 4.0 million shares to the hedge participants at an initial strike price of $70.05 per share, subject to customary anti-dilution adjustments. The earliest expiration of these warrant transactions is March 15, 2017 and they continue to expire through the 100th scheduled trading day thereafter, as defined in the indenture. The warrants could separately have a dilutive effect on the Company's earnings per share if the market price of its common stock exceeds the strike price of the warrants.
Expensed incremental financing costs					400,000
Expensed previously capitalized financing costs					400,000
Extinguishment of Debt, Amount								18,600,000	17,700,000	18,700,000	32,100,000	83,300,000
Gains (Losses) on Extinguishment of Debt		(480,000)										500,000
Common stock based on initial conversion rate ratio															15.3935					17.4092
Maximum selling price of company's common stock															130.00%					150.00%
Principal amount of notes per average trading price															1,000					1,000
Maximum average conversion value of the Notes															97.00%					98.00%
Percentage of principal for notes repurchased																			100.00%	100.00%
Cost of call transactions														46,800,000				42,900,000
Proceeds from warrant transactions														$ 21,700,000				$ 28,500,000
Strike price of the call transaction																$ 64.96				$ 57.44
Strike price of the warrant transactions													$ 77.96			$ 90.95				$ 70.05
Warrant transaction, Notes expiration																August 30, 2012 and January 23, 2013

Debt (Components Of Interest Expense) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
2016 Senior Convertible Notes [Member]
Debt Instrument [Line Items]
Non-cash interest	$ 3,740
Cash Interest	2,024
Interest expense	5,764
2012 Senior Convertible Notes [Member]
Debt Instrument [Line Items]
Non-cash interest	6,850	6,401	5,981
Cash Interest	3,919	3,919	3,919
Interest expense	10,769	10,320	9,900
2010 Senior Convertible Notes [Member]
Debt Instrument [Line Items]
Non-cash interest		1,190	4,456
Cash Interest		830	3,587
Interest expense		$ 2,020	$ 8,043

- Definition

The component of interest expense representing the noncash expenses charged against earnings in the period to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate caption: Noncash Interest Expense.

+ References+ Details

Derivative Instruments (Narrative) (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended	12 Months Ended			12 Months Ended
	Sep. 30, 2011	Dec. 31, 2011	Dec. 31, 2011 Forward Contracts [Member]	Dec. 31, 2010 Forward Contracts [Member]	Dec. 31, 2011 Foreign Currency Forward Contracts [Member]	Dec. 31, 2011 Interest Rate Swap [Member]
Derivative [Line Items]
Net pre-tax losses recorded in AOCI					$ 0.1	$ 1.6
Interest rate swap expiration date	August 10, 2015
Period for interest rate hedge to be reclassified to earnings	twelve months
Gross notional amount of derivative instruments not designated as hedging instruments, outstanding			3.3	0
Fair value of derivative instruments not designated as hedging instruments			0.1
Gains/ (losses) of derivative instruments not designated as hedging instruments		$ 0.3

Derivative Instruments (Summary Of Fair Value In Balance Sheet For Derivatives Designated As Hedging Instruments) (Details) (USD $)

12 Months Ended

Dec. 31, 2011

Dec. 31, 2010

Derivative [Line Items]

Derivative Fair Value Of Derivative Liability

$ 4,200,000

^[1]

$ 2,095,000

^[1]

Interest Rate Swap [Member]

Derivative [Line Items]

Derivative Fair Value Of Derivative Asset

1,825,000

^[1],[2]

Notional amount of interest rate derivatives

139,700,000

148,100,000

Reduction in notional amount of interest rate derivatives in next twelve months

12,200,000

8,400,000

Accrued Expenses And Other Current Liabilities [Member] | Interest Rate Swap [Member]

Derivative [Line Items]

Derivative Fair Value Of Derivative Liability

1,634,000

^[1],[2]

2,095,000

^[1],[2]

Accrued Expenses And Other Current Liabilities [Member] | Foreign Currency Forward Contracts [Member]

Derivative [Line Items]

Derivative Fair Value Of Derivative Liability

108,000

^[1]

Notional amount of foreign currency derivatives

1,597,000

^[1]

Other Liabilities [Member] | Interest Rate Swap [Member]

Derivative [Line Items]

Derivative Fair Value Of Derivative Liability

$ 2,458,000

^[1],[2]

[1]	The Company classifies derivative assets and liabilities as current based on the cash flows expected to be incurred within the following 12 months.
[2]	At December 31, 2011 and 2010, the total notional amount related to the interest rate swap was $139.7 million and $148.1 million, respectively. In the subsequent twelve months the Company expects to reduce these amounts by $12.2 million and $8.4 million, respectively.

- Definition

Fair value of derivative asset, presented on a gross basis even when the derivative instrument is subject to master netting arrangements and qualifies for net presentation in the statement of financial position.

+ References+ Details

- Definition

Fair value of derivative liability, presented on a gross basis even when the derivative instrument is subject to master netting arrangements and qualifies for net presentation in the statement of financial position.

+ References+ Details

Derivative Instruments (Effect Of Derivative Instruments Designated As Cash Flow Hedges On Statements Of Operations) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Derivative [Line Items]
Amount of Gain (Loss) Recognized in AOCI-Effective Portion	$ (6,306)	$ 2,486
Amount of Gain (Loss) Reclassified from AOCI Into Earnings-Effective Portion	(2,269)	2,782
Cost Of Product Revenue [Member] \| Foreign Currency Forward Contracts [Member]
Derivative [Line Items]
Amount of Gain (Loss) Recognized in AOCI-Effective Portion	(216)
Other Income (Expense) [Member] \| Foreign Currency Forward Contracts [Member]
Derivative [Line Items]
Amount of Gain (Loss) Recognized in AOCI-Effective Portion		2,756
Amount of Gain (Loss) Reclassified from AOCI Into Earnings-Effective Portion		2,782
Interest (Expense) [Member] \| Interest Rate Swap [Member]
Derivative [Line Items]
Amount of Gain (Loss) Recognized in AOCI-Effective Portion	(6,090)	(270)
Amount of Gain (Loss) Reclassified from AOCI Into Earnings-Effective Portion	$ (2,269)

- Definition

The effective portion of net gain (loss) reclassified from accumulated other comprehensive income into income on derivative instruments designated and qualifying as hedging instruments.

+ References+ Details

- Definition

The effective portion of gains and losses (net) on derivative instruments designated and qualifying as hedging instruments that was recognized in other comprehensive income during the current period.

+ References+ Details

Treasury Stock (Narrative) (Details) (USD $) In Millions, unless otherwise specified	9 Months Ended	1 Months Ended	12 Months Ended
	Sep. 30, 2011	Oct. 29, 2010 2008 Authorization [Member]	Dec. 31, 2011 2008 Authorization [Member]	Dec. 31, 2011 2010 Authorization [Member]
Equity, Class of Treasury Stock [Line Items]
Shares repurchased, authorization date			Oct. 30, 2008	Oct. 29, 2010
Stock repurchase program, authorized amount		$ 75.0		$ 75.0
Amount available for share repurchase under this latest authorization	$ 29.1

Treasury Stock (Schedule Of Treasury Stock Activity) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Equity, Class of Treasury Stock [Line Items]
Shares repurchased, amount	$ 83,463	$ 31,278
Shares repurchased, number of shares	1,909	858
2008 Authorization [Member]
Equity, Class of Treasury Stock [Line Items]
Shares repurchased, amount		31,278
Shares repurchased, number of shares		858
2010 Authorization [Member]
Equity, Class of Treasury Stock [Line Items]
Shares repurchased, amount	45,893
Shares repurchased, number of shares	1,104
2016 Senior Convertible Notes [Member]
Equity, Class of Treasury Stock [Line Items]
Shares repurchased, amount	$ 37,570
Shares repurchased, number of shares	805

- Definition

Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.

+ References+ Details

Stock Purchase And Award Plans (Narrative) (Details) (USD $)	12 Months Ended						1 Months Ended			9 Months Ended	12 Months Ended								3 Months Ended		12 Months Ended	3 Months Ended			1 Months Ended		12 Months Ended	0 Months Ended		1 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009	Dec. 31, 2011 1999, 2000 And 2001 Plan [Member]	Dec. 31, 2011 1998 Plan [Member]	Dec. 31, 2011 1993 And 1996 Plan [Member]	May 31, 2010 2003 Plan [Member]	Jul. 31, 2008 2003 Plan [Member]	Dec. 31, 2011 2003 Plan [Member]	Sep. 30, 2011 Restricted Stock [Member]	Dec. 31, 2011 Restricted Stock [Member]	Dec. 31, 2011 Stock Options [Member]	Dec. 31, 2011 Restricted Stock, Performance Stock And Contract Stock [Member]	Dec. 31, 2010 Restricted Stock, Performance Stock And Contract Stock [Member]	Dec. 31, 2009 Restricted Stock, Performance Stock And Contract Stock [Member]	Dec. 31, 2011 Employee Stock Purchase Plan [Member]	Dec. 31, 2010 Employee Stock Purchase Plan [Member]	Dec. 31, 2009 Employee Stock Purchase Plan [Member]	Dec. 31, 2011 Former Chief Executive Officer [Member]	Jun. 30, 2011 Former Chief Executive Officer [Member]	Dec. 31, 2011 Former Chief Executive Officer [Member]	Dec. 31, 2011 Former Chief Executive Officer [Member] 2011 Minimum Award [Member]	Dec. 31, 2011 Former Chief Executive Officer [Member] Accelerated Vesting Of Previous Award [Member]	Jun. 30, 2011 Former Chief Executive Officer [Member] Selling and Marketing Expense [Member] Contract Stock/Stock Units [Member]	Aug. 31, 2008 Former Chief Executive Officer [Member] Chief Executive Officer [Member] Restricted Stock Units (RSUs) [Member]	Jul. 31, 2004 Former Chief Executive Officer [Member] Chief Executive Officer [Member] Restricted Stock Units (RSUs) [Member]	Dec. 31, 2008 Former Chief Executive Officer [Member] Chief Executive Officer [Member] Restricted Stock Units (RSUs) [Member]	May 17, 2011 Former Chief Executive Officer [Member] Chief Executive Officer [Member] Contract Stock/Stock Units [Member]	Dec. 31, 2011 Non Former Chief Executive Officer [Member] Restricted Stock [Member]	Oct. 31, 2010 Current Chief Executive Officer [Member] Chief Executive Officer [Member] Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%	0.00%	0.00%
Common stock reserved for issuance				2,000,000	1,000,000	750,000			6,500,000							1,500,000
Shares available for purchase	1,900,000															1,100,000
Non issued vested restricted stock units																													430,000
Shares issued																8,523	5,515	7,263							375,000	750,000		165,000		34,868
Increase in authorized shares							1,750,000	750,000
Discount percentage available to participants																5.00%
Requisite service periods of performance stock, restricted stock and contract stock awards	3 years
Share based expense recognized	$ 26,805,000	$ 17,209,000	$ 15,580,000										$ 24,500,000	$ 13,500,000	$ 10,500,000				$ 4,900,000	$ 8,400,000		$ 2,300,000	$ 2,600,000	$ 8,400,000			$ 18,000,000			$ 1,500,000
ESPP proceeds received																200,000	200,000	300,000
Period in which stock options issued become exercisable from date of grant, years										three		four
Expiration for employees, in years	6Y
Intrinsic value of options exercised in period	1,400,000	14,400,000	1,000,000
Weighted average grant date fair value of options granted	$ 19.18	$ 17.03	$ 8.12
Cash received from option exercises	3,700,000	16,100,000	6,600,000
Former CEO annual equity grant, minimum	75,000
Former CEO annual equity grant, maximum	100,000
Total unrecognized compensation costs related to unvested awards												200,000	7,400,000
Weighted-average period for cost recognition, years											2	1
Period common stock shall be delivered to Executive following anniversary of separation of service, days																					3
Anniversary of separation of service, months																					6
Fair market value of shares vested	$ 29,700,000	$ 11,500,000	$ 4,700,000

Stock Purchase And Award Plans (Summary Of Employee Stock-Based Compensation Expense) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total employee stock-based compensation expense	$ 26,805	$ 17,209	$ 15,580
Total tax benefit related to employee stock-based compensation expense	10,468	7,006	6,253
Net effect on net income	16,337	10,203	9,327
Selling, General And Administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total employee stock-based compensation expense	26,310	16,694	14,958
Cost of Product Revenues [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total employee stock-based compensation expense	91	89	130
Research And Development Expense [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Total employee stock-based compensation expense	$ 404	$ 426	$ 492

- Definition

Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.

+ References+ Details

Stock Purchase And Award Plans (Summary Of Weighted-Average Assumptions) (Details)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Stock Purchase And Award Plans [Abstract]
Dividend yield	0.00%	0.00%	0.00%
Expected volatility	28.00%	30.00%	29.00%
Risk free interest rate	2.47%	2.82%	2.00%
Expected life of option from grant date, in years	8	8	8

- Definition

The period of time an equity-based award is expected to be outstanding. An equity-based award's expected term is generally determined based on, among other factors, the instrument's contractual term and the effects of employees' expected exercise and post-vesting employment termination behavior.

+ References+ Details

Stock Purchase And Award Plans (Summary Of Stock Option Activity) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Stock Purchase And Award Plans [Abstract]
Share, Outstanding at beginning of year	1,560
Shares, Granted	34
Shares, Exercised	(100)
Shares, Forfeited or Expired	(11)
Shares, Outstanding at end of year	1,483
Shares, Vested or expected to vest at end of year	1,483
Shares, Exercisable at end of year	1,465
Weighted Average Exercise Price, Outstanding at beginning of year	$ 38.13
Weighted Average Exercise Price, Granted	$ 50.78
Weighted Average Exercise Price, Exercised	$ 34.43
Weighted Average Exercise Price, Forfeited or Expired	$ 36.60
Weighted Average Exercise Price, Outstanding at end of year	$ 38.68
Weighted Average Exercise Price, Vested or expected to vest at end of year	$ 38.68
Weighted Average Exercise Price, Exercisable at end of year	$ 38.54
Aggregate Intrinsic Value, Outstanding at end of year	$ 270
Aggregate Intrinsic Value, Vested or expected to vest at end of year	270
Aggregate Intrinsic Value, Exercisable at end of year	$ 270
Weighted Average Contractual Term (Years), Outstanding at end of year	4.4
Weighted Average Contractual Term (Years), Vested or expected to vest at end of year	4.4
Weighted Average Contractual Term (Years), Exercisable at end of year	4.4

Stock Purchase And Award Plans (Summary Of Vested And Unvested RSU) (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2011
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested beginning balance, shares	413
Granted, shares	122
Cancellations, shares	(35)
Unvested ending balance, shares	305
Unvested beginning balance, value	$ 34.98
Granted, value	$ 47.48
Cancellations, value	$ 37.99
Unvested ending balance, value	$ 38.37
Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested beginning balance, shares	277
Granted, shares	361
Cancellations, shares	(6)
Unvested ending balance, shares	144
Unvested beginning balance, value	$ 40.74
Granted, value	$ 40.29
Cancellations, value	$ 40.66
Unvested ending balance, value	$ 29.15
Released [Member] \| Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, shares	(195)
Vested, value	$ 36.95
Released [Member] \| Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, shares	(9)
Vested, value	$ 44.51
Vested But Not Released [Member] \| Stock Appreciation Rights (SARs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, shares	(479)
Vested, value	$ 43.83

- Definition

The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References+ Details

- Definition

The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.

+ References+ Details

- Definition

The weighted average fair value of nonvested awards on equity-based plans excluding option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, revenue or profit achievement stock award plan) for which the employer is contingently obligated to issue equity instruments or transfer assets to an employee who has not yet satisfied service or performance criteria necessary to gain title to proceeds from the sale of the award or underlying shares or units.

+ References+ Details

- Definition

The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.

+ References+ Details

Retirement Benefit Plans (Narrative) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Retirement Benefit Plans [Abstract]
Reduction in projected benefit obligations	$ 0.3
Accumulated benefit obligation for the defined benefit plans	12.6	11.9
Total contributions made by the Company	2.4	2.0	1.7
Anticipated company contributions to defined benefit plans	0.8
Unrecognized accumulated other comprehensive loss	$ 0.2

- Definition

For defined benefit pension plans, the actuarial present value of benefits (whether vested or nonvested) attributed by the pension benefit formula to employee service rendered before a specified date and based on employee service and compensation (if applicable) before that date. The accumulated benefit obligation differs from the projected benefit obligation in that it includes no assumption about future compensation levels. For plans with flat-benefit or nonpay-related pension benefit formulas, the accumulated benefit obligation and the projected benefit obligation are the same.

+ References+ Details

- Definition

The amount of decrease that is related to an event that significantly reduces the expected years of future service of present employees or eliminates for a significant number of employees the accrual of defined benefits for some or all of their future services.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Number 88

-Name Statement of Financial Accounting Standard (FAS)

-Paragraph 6

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(10)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 30

-Section 15

-Paragraph 6

-Subparagraph (a)(2)

-URI http://asc.fasb.org/extlink&oid=6412315&loc=d3e8001-114927

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Plan Curtailment

-URI http://asc.fasb.org/extlink&oid=6520938

+ Details

Retirement Benefit Plans (Net Periodic Benefit Costs For Defined Benefit Pension Plans) (Details) (Foreign Pension Plans, Defined Benefit [Member], USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Foreign Pension Plans, Defined Benefit [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Service cost	$ 26	$ 93	$ 121
Interest cost	650	645	605
Expected return on plan assets	(589)	(515)	(413)
Recognized net actuarial loss		86	307
Net periodic benefit income cost	$ 87	$ 309	$ 620

- Definition

An amount calculated as a basis for determining the extent of delayed recognition of the effects of changes in the fair value of assets. The expected return on plan assets is determined based on the expected long-term rate of return on plan assets and the market-related value of plan assets.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph h

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(3)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Expected Return on Plan Assets

-URI http://asc.fasb.org/extlink&oid=6512136

-Topic 715

-SubTopic 30

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Expected Return on Plan Assets

-URI http://asc.fasb.org/extlink&oid=6512171

-Topic 715

-SubTopic 60

+ Details

- Definition

The increase in a defined benefit pension plan's projected benefit obligation or a defined benefit postretirement plan's accumulated postretirement benefit obligation due to the passage of time.

+ References+ Details

- Definition

The actuarial present value of benefits attributed by the pension benefit formula to services rendered by employees during the period. The portion of the expected postretirement benefit obligation attributed to employee service during the period. The service cost component is a portion of the benefit obligation and is unaffected by the funded status of the plan.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 106

-Paragraph 518

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 87

-Paragraph 264

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 132R

-Paragraph 5

-Subparagraph a, h

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (h)(1)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 715

-SubTopic 20

-Section 50

-Paragraph 1

-Subparagraph (a)(1)

-URI http://asc.fasb.org/extlink&oid=6962843&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Service Cost (Component of Net Periodic Pension Cost)

-URI http://asc.fasb.org/extlink&oid=6525008

+ Details

Retirement Benefit Plans (Weighted Average Assumptions) (Details)	12 Months Ended
	Dec. 31, 2009 Foreign Pension Plans, Defined Benefit [Member]	Dec. 31, 2011 Foreign Postretirement Benefit Plans, Defined Benefit [Member]	Dec. 31, 2010 Foreign Postretirement Benefit Plans, Defined Benefit [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Discount rate	5.90%	4.70%	5.40%
Expected return on plan assets	5.40%	2.90%	5.20%
Rate of compensation increase	3.70%		3.40%

- Definition

An assumption as to the rate of return on plan assets reflecting the average rate of earnings expected on the funds invested or to be invested to provide for the benefits included in the benefit obligation.

+ References+ Details

Retirement Benefit Plans (Changes In Projected Benefit Obligation And Fair Value Of Plan Assets) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Curtailment gain	$ 300
Plan assets at fair value, beginning of year	10,834
Plan assets at fair value, end of year	13,226
Change In Projected Benefit Obligation [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Projected benefit obligation, beginning of year	12,042	11,550
Service cost	26	93
Interest cost	650	645
Participant contributions	5	17
Benefits paid	(688)	(464)
Actuarial loss (gain)	610	551
Curtailment gain	(116)
Effect of foreign currency exchange rates	27	(350)
Projected benefit obligation, end of year	12,556	12,042
Change In Plan Assets [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Participant contributions	11	17
Benefits paid	(678)	(444)
Plan assets at fair value, beginning of year	10,834	9,302
Actual return on plan assets	1,970	1,070
Employer contributions	1,115	1,157
Effect of foreign currency exchange rates	(26)	(268)
Plan assets at fair value, end of year	$ 13,226	$ 10,834

Retirement Benefit Plans (Schedule Of Reconciliation Of Funded Status) (Details) (Foreign Postretirement Benefit Plans, Defined Benefit [Member], USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Foreign Postretirement Benefit Plans, Defined Benefit [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Funded status, projected benefit obligation in excess of (less than) plan assets	$ 670	$ (1,208)
Unrecognized net actuarial loss	199	1,061
Accumulated other comprehensive loss	(199)	(1,061)
Amounts recognized	$ 670	$ (1,208)

Retirement Benefit Plans (Schedule Of Weighted Average Allocation Of Plan Assets) (Details) (Foreign Postretirement Benefit Plans, Defined Benefit [Member])	Dec. 31, 2011	Dec. 31, 2010
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Equity Securities		19.00%
Cash	3.00%	2.00%
Weighted-average allocation of plan assets, total	100.00%	100.00%
US Treasury And Government [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Debt securities	97.00%	46.00%
Corporate Debt Securities [Member]
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
Debt securities		33.00%

Retirement Benefit Plans (Schedule Of Pension Plan Assets At Fair Value) (Details) (USD $)
In Thousands, unless otherwise specified

Dec. 31, 2011

Dec. 31, 2010

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

$ 13,226

$ 10,834

Fair Value, Inputs, Level 1 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

344

300

Fair Value, Inputs, Level 2 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

12,882

10,534

Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

Cash And Cash Equivalents [Member] | Bank Account [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

344

254

Cash And Cash Equivalents [Member] | Bank Account [Member] | Fair Value, Inputs, Level 1 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

344

254

Cash And Cash Equivalents [Member] | Bank Account [Member] | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

Cash And Cash Equivalents [Member] | Baillie Gifford-Managed Pension Fund [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

^[1]

Cash And Cash Equivalents [Member] | Baillie Gifford-Managed Pension Fund [Member] | Fair Value, Inputs, Level 1 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

^[1]

Cash And Cash Equivalents [Member] | Baillie Gifford-Managed Pension Fund [Member] | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

^[1]

Government Bonds [Member] | Legal & General Over 15 Year Gilts Index [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

1,765

^[2]

Government Bonds [Member] | Legal & General Over 15 Year Gilts Index [Member] | Fair Value, Inputs, Level 2 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

1,765

^[2]

Equity Securities [Member] | Baillie Gifford-Managed Pension Fund [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

2,012

^[1]

Equity Securities [Member] | Baillie Gifford-Managed Pension Fund [Member] | Fair Value, Inputs, Level 2 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

2,012

^[1]

Equity Securities [Member] | Baillie Gifford-Managed Pension Fund [Member] | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

^[1]

Foreign Government Debt Securities [Member] | Legal & General Over 15 Year Index-Linked Gilts Index [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

11,117

^[3]

4,949

^[3]

Foreign Government Debt Securities [Member] | Legal & General Over 15 Year Index-Linked Gilts Index [Member] | Fair Value, Inputs, Level 2 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

11,117

^[3]

4,949

^[3]

Foreign Government Debt Securities [Member] | Legal & General Over 15 Year Index-Linked Gilts Index [Member] | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

^[3]

Corporate Debt Securities [Member] | Baillie Gifford-Managed Pension Fund [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

134

^[1]

Corporate Debt Securities [Member] | Baillie Gifford-Managed Pension Fund [Member] | Fair Value, Inputs, Level 2 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

134

^[1]

Corporate Debt Securities [Member] | Baillie Gifford-Managed Pension Fund [Member] | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

^[1]

Corporate Debt Securities [Member] | Baillie Gifford-Investment Grade-Long Bond Fund [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

3,439

^[4]

Corporate Debt Securities [Member] | Baillie Gifford-Investment Grade-Long Bond Fund [Member] | Fair Value, Inputs, Level 2 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

3,439

^[4]

Corporate Debt Securities [Member] | Baillie Gifford-Investment Grade-Long Bond Fund [Member] | Fair Value, Inputs, Level 3 [Member]

Defined Benefit Plan Disclosure [Line Items]

Defined Benefit Plan, Fair Value of Plan Assets

^[4]

[1]	This category represents a pooled fund consisting of holdings in a range of UK and overseas equities and bonds, and cash.
[2]	This category represents a fund consisting of gilts and is designed to follow a benchmark index.
[3]	This category represents funds consisting of index-linked gilts and is designated to follow a benchmark index.
[4]	This category represents a diversified portfolio of investment-grade fixed-interest securities.

- Definition

Assets, usually stocks, bonds, and other investments, that have been segregated and restricted (usually in a trust) to provide benefits, at their fair value as of the measurement date. Plan assets include amounts contributed by the employer (and by employees for a contributory plan) and amounts earned from investing the contributions, less benefits paid. If a plan has liabilities other than for benefits, those non-benefit obligations may be considered as reductions of plan assets.

+ References+ Details

Retirement Benefit Plans (Schedule of Expected Benefit Payments) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Retirement Benefit Plans [Abstract]
2012	$ 480
2013	518
2014	549
2015	583
2016	614
2017-2021	$ 3,520

Leases And Related Party Leases (Narrative) (Details) (USD $) In Millions, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Operating Leased Assets [Line Items]
Total rental expense	$ 9.3	$ 8.2	$ 8.1
Related Party [Member]
Operating Leased Assets [Line Items]
Total rental expense	0.9	0.8	0.9
Term of lease	March 31, 2022
Option to renew lease	March 31, 2032
Payment per year to related party lessor	0.1
Percent of manufacturing facility owned by corporation whose shareholders are trusts whose beneficiaries include family members of company's former chairman	50.00%
Term of current lease agreement	October 31, 2017
Annual rate of lease agreement	0.3
Option to extend lease, years	15
Period for extended lease	November 1, 2017 through October 31, 2032
Annual rate for extended lease	$ 0.3
Five-Year Option Lease From November 1, 2032 Through October 31, 2037 [Member]
Operating Leased Assets [Line Items]
Option to extend lease, years	5
Period for extended lease	November 1, 2032 through October 31, 2037
Five-Year Option Lease From November 1, 2037 Through October 31, 2042 [Member]
Operating Leased Assets [Line Items]
Option to extend lease, years	5
Period for extended lease	November 1, 2037 through October 31, 2042

Leases And Related Party Leases (Schedule Of Minimum Lease Payments) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011
Operating Leased Assets [Line Items]
2012	$ 12,112
2013	11,184
2014	9,807
2015	6,260
2016	3,442
Thereafter	5,395
Total minimum lease payments	48,200
Related Parties [Member]
Operating Leased Assets [Line Items]
2012	1,009
2013	1,027
2014	1,027
2015	974
2016	974
Thereafter	1,879
Total minimum lease payments	6,890
Third Parties [Member]
Operating Leased Assets [Line Items]
2012	11,103
2013	10,157
2014	8,780
2015	5,286
2016	2,468
Thereafter	3,516
Total minimum lease payments	$ 41,310

- Definition

The total of future contractually required payments on leases defined as operating.

+ References+ Details

- Definition

For leases having an initial or remaining non-cancelable letter-terms in excess of one year, required rental payments due within one year of the balance sheet date relating to leases defined as operating.

+ References+ Details

- Definition

For leases having an initial or remaining non-cancelable letter-terms in excess of one year, required rental payments due within the fifth year of the balance sheet date relating to leases defined as operating.

+ References+ Details

- Definition

For leases having an initial or remaining non-cancelable letter-terms in excess of one year, required rental payments due within the fourth year of the balance sheet date relating to leases defined as operating.

+ References+ Details

- Definition

For leases having an initial or remaining non-cancelable letter-terms in excess of one year, required rental payments due within the third year of the balance sheet date relating to leases defined as operating.

+ References+ Details

- Definition

For leases having an initial or remaining non-cancelable letter-terms in excess of one year, required rental payments due within the second year of the balance sheet date relating to leases defined as operating.

+ References+ Details

- Definition

For leases having an initial or remaining non-cancelable letter-terms in excess of one year, required rental payments due after the fifth year from the balance sheet date on leases defined as operating.

+ References+ Details

Income Taxes (Narrative) (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended		12 Months Ended
	Dec. 31, 2011	Jun. 30, 2011	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Tax [Line Items]
Deferred tax expense (benefit) corrections recorded in current period relating to prior periods	$ (2.2)	$ 1.7
Net operating loss carryforwards expiry period			2030
Net operating loss carryforwards subject to expiration	66.7		66.7
Undistributed earnings of foreign subsidiaries	168.8		168.8	142.2	101.4
Valuation allowance	32.3		32.3	36.6	36.1
Gross deferred tax assets	125.9		125.9	112.9	114.0
Valuation allowance increase (decrease)			(4.3)	0.5
Uncertain tax positions	3.1		3.1
Tax positions that could significantly change total amounts in next twelve months	1.6		1.6
Recognized tax (benefit) expense related to interest and penalties for uncertain tax positions			(0.5)	(0.9)	0.5
Accrued interest and penalties	1.3		1.3	2.1	3.0
Accrued unrecognized tax benefits					8.5
Uncertain taxes reclassified				4.0
Audits settled during the year				2005 through 2007
Reclassification of current taxes payable and deferred taxes				4.5
Operating loss carryforwards, limitations on use			At December 31, 2011 and 2010, several of the Company's subsidiaries had unused net operating loss carryforwards and tax credit carryforwards arising from periods prior to the Company's ownership which expire through 2030. The Internal Revenue Code limits the timing and manner in which the Company may use any acquired net operating losses or tax credits.
Federal income tax benefit relating to settlement			0.1
Internal Revenue Service (IRS) [Member]
Income Tax [Line Items]
Net operating loss carryforwards	61.3		61.3
Year through which tax returns are no longer subject to audit			2007
Operating Loss Carryforwards, Expiration Dates			2030
Foreign Country [Member]
Income Tax [Line Items]
Net operating loss carryforwards	73.1		73.1
Net operating loss carryforwards with an indefinite carry forward period	6.3		6.3
Year through which tax returns are no longer subject to audit			2005
Operating Loss Carryforwards, Expiration Dates			2020
State and Local Jurisdiction [Member]
Income Tax [Line Items]
Net operating loss carryforwards	$ 31.7		$ 31.7
Year through which tax returns are no longer subject to audit			2004
Operating Loss Carryforwards, Expiration Dates			2030

Income Taxes (Schedule Of Income Before Income Taxes) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
United States operations	$ 1,507	$ 37,026	$ 40,497
Foreign operations	26,987	45,088	32,655
Income before income taxes	$ 28,494	$ 82,114	$ 73,152

Income Taxes (Schedule of Effective Tax Rate Reconciliation) (Details)	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Federal statutory rate	35.00%	35.00%	35.00%
State income taxes, net of federal tax benefit	6.00%	2.60%	2.60%
Foreign operations	(18.10%)	(10.30%)	(9.90%)
Incentive stock option expense		(0.30%)	(0.20%)
Change in valuation allowances	(14.00%)	1.70%	4.40%
Uncertain tax positions	(5.80%)	(4.60%)
Other	(1.30%)	(4.10%)	(1.60%)
Effective Tax Rate	1.80%	20.00%	30.30%

- Definition

A ratio calculated by dividing the reported amount of income tax expense attributable to continuing operations for the period by GAAP-basis pretax income from continuing operations.

+ References+ Details

- Definition

The domestic federal statutory tax rate applicable under enacted tax laws to the Company's pretax income from continuing operations for the period. The "statutory" tax rate is the regular tax rate if there are alternative tax systems.

+ References+ Details

Income Taxes (Schedule Of Provision For Income Taxes) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Federal	$ (934)	$ 2,686	$ 9,106
State	(1,530)	1,136	4,021
Foreign	1,813	8,495	8,522
Total Current	(651)	12,317	21,649
Federal	1,078	2,522	1,281
State	2,236	835	(672)
Foreign	(2,158)	771	(61)
Deferred Income Tax Expense (Benefit)	1,156	4,128	548
Provision for income taxes	$ 505	$ 16,445	$ 22,197

Income Taxes (Schedule Of Deferred Tax Assets And Liabilities) (Details) (USD $) In Thousands, unless otherwise specified	Dec. 31, 2011	Dec. 31, 2010
Income Tax [Line Items]
Doubtful Accounts	$ 1,822	$ 2,033
Inventory reserves	24,695	25,131
Tax credits	2,865	1,469
Accrued vacation	2,163	2,082
Accrued bonus	2,330	3,126
Total current deferred tax assets	37,007	38,929
Less valuation allowance	(702)	(852)
Current deferred tax assets after valuation allowance	36,305	38,077
Total current deferred tax liabilities	(179)	(3,872)
Net current deferred tax assets	36,126	34,205
Benefits and compensation	8,991	9,616
Stock compensation	28,659	19,770
Deferred revenue	148	389
Net operating loss carryforwards	48,251	35,223
Other		2,801
Total non-current deferred tax assets	88,854	73,997
Less valuation allowance	(31,602)	(35,782)
Non-current deferred tax assets after valuation allowance	57,252	38,215
Intangible and fixed assets	(43,152)	(31,751)
Deferred gain	(548)	(449)
Other	(191)	(4,053)
Total non current deferred tax liabilities	(45,738)	(40,966)
Net non-current deferred tax assets/(liabilities)	11,514	(2,751)
Total net deferred tax assets/(liabilities)	47,640	31,454
Financing Costs [Member]
Income Tax [Line Items]
Deferred tax assets, other	1,472	4,493
Other [Member]
Income Tax [Line Items]
Deferred tax assets, other	3,132	5,088
Federal And State Tax Credits [Member]
Income Tax [Line Items]
Deferred tax assets, other	1,333	1,705
Other Current [Member]
Income Tax [Line Items]
Other	(179)	(3,872)
Non-Cash Interest Amortization [Member]
Income Tax [Line Items]
Other	$ (1,847)	$ (4,713)

Income Taxes (Schedule of Uncertain Tax Benefits Reconciliation) (Details) (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Income Taxes [Abstract]
Balance, beginning of year	$ 5,530	$ 10,909	$ 9,033
Additions for tax positions of prior years	1,001	1,685	3,785
Settlements	(962)	(5,264)
Lapse of statute	(1,642)	(1,800)	(1,909)
Balance, end of year	$ 3,927	$ 5,530	$ 10,909

Net Income Per Share (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net income	$ 4,560	$ 11,243	$ 699	$ 11,487	$ 18,807	$ 16,483	$ 15,157	$ 15,222	$ 27,989	$ 65,669	$ 50,955
Weighted average common shares outstanding - Basic									28,952,000	29,548,000	29,038,000
Basic net income per common share									$ 0.97	$ 2.21	$ 1.75
Stock options and restricted stock									543,000	601,000	254,000
Weighted average common shares for diluted earnings per share									29,495,000	30,149,000	29,292,000
Diluted net income per share									$ 0.95	$ 2.17	$ 1.74
Impact of participating securities on rounding of earning or loss per share									$ 0.01
Stock Compensation Plan [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Shares excluded from computation as their effect would be antidilutive									300,000	700,000	2,100,000
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Additional EPS shares	1,800,000								1,800,000

Commitments And Contingencies (Details) (USD $) In Millions, unless otherwise specified	1 Months Ended			12 Months Ended
	Jun. 30, 2011	Jan. 31, 2011	Jan. 31, 2010	Dec. 31, 2011
Commitments And Contingencies [Abstract]
The Company allegedly owes an additional payment related to revenue performance of trade sales		$ 6.7
Original accrual amount for settlement			3.4
Expense accrued by company in the estimate of settlement	4.6
The alleged total amount owed was reduced to this amount		5.7
Significant of product liability claims settled				$ 4.6

Segment And Geographic Information (Revenues By Market Category) (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended								12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2010	Sep. 30, 2010	Jun. 30, 2010	Mar. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Segment Reporting Information [Line Items]
Total revenue, net	$ 203,523	$ 202,185	$ 193,329	$ 181,041	$ 194,134	$ 186,641	$ 178,595	$ 172,698	$ 780,078	$ 732,068	$ 682,487
Orthopedics [Member]
Segment Reporting Information [Line Items]
Total revenue, net									328,782	290,050	262,170
Neurosurgery [Member]
Segment Reporting Information [Line Items]
Total revenue, net									285,341	275,046	256,544
Instruments [Member]
Segment Reporting Information [Line Items]
Total revenue, net									$ 165,955	$ 166,972	$ 163,773

Segment And Geographic Information (Revenue And Long-Lived Assets By Geographic Area) (Details) (USD $)
In Thousands, unless otherwise specified

3 Months Ended

12 Months Ended

Dec. 31, 2011

Sep. 30, 2011

Jun. 30, 2011

Mar. 31, 2011

Dec. 31, 2010

Sep. 30, 2010

Jun. 30, 2010

Mar. 31, 2010

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Segment Reporting Information [Line Items]

Total revenue, net

$ 203,523

$ 202,185

$ 193,329

$ 181,041

$ 194,134

$ 186,641

$ 178,595

$ 172,698

$ 780,078

$ 732,068

$ 682,487

Long-Lived Assets

144,511

109,558

144,511

109,558

United States [Member]

Segment Reporting Information [Line Items]

Total revenue, net

593,036

^[1]

561,240

^[1]

519,203

^[1]

Long-Lived Assets

125,880

^[1]

94,012

^[1]

125,880

^[1]

94,012

^[1]

Europe [Member]

Segment Reporting Information [Line Items]

Revenue from foreign countries

94,772

89,381

93,414

Long-Lived Assets

17,274

14,142

17,274

14,142

Asia Pacific [Member]

Segment Reporting Information [Line Items]

Revenue from foreign countries

44,445

40,584

32,788

Long-Lived Assets

934

935

934

935

Other Foreign [Member]

Segment Reporting Information [Line Items]

Revenue from foreign countries

47,825

^[2]

40,863

^[2]

37,082

^[2]

Long-Lived Assets

$ 423

^[2]

$ 469

^[2]

$ 423

^[2]

$ 469

^[2]

[1]	Includes long-lived assets in Puerto Rico
[2]	Represents: Canada, Latin America, Africa and the Middle East

Selected Quarterly Information (Narrative) (Details) (USD $)	3 Months Ended				12 Months Ended
	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2011	Mar. 31, 2011	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2009
Selected Quarterly Information [Line items]
Share based expense recognized					$ 26,805,000	$ 17,209,000	$ 15,580,000
Global ERP implementation costs	3,600,000	5,100,000	2,400,000	2,500,000
FDA remediation costs	4,000,000	1,700,000
Deferred tax expense (benefit) corrections recorded in current period relating to prior periods	(2,200,000)		1,700,000
Former Chief Executive Officer [Member]
Selected Quarterly Information [Line items]
Share based expense recognized	$ 4,900,000		$ 8,400,000

- Definition

+ References+ Details

Selected Quarterly Information (Selected Quarterly Information) (Details) (USD $)
In Thousands, except Per Share data, unless otherwise specified

3 Months Ended

12 Months Ended

Dec. 31, 2011

Sep. 30, 2011

Jun. 30, 2011

Mar. 31, 2011

Dec. 31, 2010

Sep. 30, 2010

Jun. 30, 2010

Mar. 31, 2010

Dec. 31, 2011

Dec. 31, 2010

Dec. 31, 2009

Total Revenue

$ 203,523

$ 202,185

$ 193,329

$ 181,041

$ 194,134

$ 186,641

$ 178,595

$ 172,698

$ 780,078

$ 732,068

$ 682,487

Gross Margin

120,783

123,534

120,491

116,120

122,828

117,447

114,131

109,474

Net income (loss)

$ 4,560

$ 11,243

$ 699

$ 11,487

$ 18,807

$ 16,483

$ 15,157

$ 15,222

$ 27,989

$ 65,669

$ 50,955

Basic net income (loss) per common share

$ 0.16

^[1],[2]

$ 0.39

^[1],[2]

$ 0.02

^[1],[2]

$ 0.39

^[1],[2]

$ 0.64

^[1],[2]

$ 0.56

^[1],[2]

$ 0.51

^[1],[2]

$ 0.51

^[1],[2]

Diluted net income (loss) per common share

$ 0.16

^[1],[2]

$ 0.39

^[1],[2]

$ 0.02

^[1],[2]

$ 0.38

^[1],[2]

$ 0.63

^[1],[2]

$ 0.55

^[1],[2]

$ 0.50

^[1],[2]

$ 0.50

^[1],[2]

Maximum [Member]

Impact of restatement on earnings per share

$ 0.01

[1]

[2]

- Definition

Expressed in per-share terms, the dollar amount of the impact of a restatement of the results of operations of a prior period on the Diluted Earnings Per Share data given for the prior period or periods.

+ References+ Details

- Definition

The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 942

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.9-04.23)

-URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 20

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 7

-Paragraph 18

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 21

-Article 9

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 40

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 128

-Paragraph 11, 12, 36, 37, 38

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.21)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6920599&loc=d3e1252-109256

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 07-4

-Paragraph 4

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 220

-SubTopic 10

-Section 45

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6920043&loc=d3e565-108580

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.22)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph A7

-Appendix A

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph d

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 225

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SX 210.5-03.18)

-URI http://asc.fasb.org/extlink&oid=6880815&loc=d3e20235-122688

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 944

-SubTopic 225

-Section S99

-Paragraph 1

-Subparagraph (SX 210.7-04.19)

-URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Emerging Issues Task Force (EITF)

-Number 87-21

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher AICPA

-Name Accounting Research Bulletin (ARB)

-Number 51

-Paragraph 38

-Subparagraph a

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 130

-Paragraph 10, 15

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 95

-Paragraph 28, 29, 30

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 5

-Section 03

-Paragraph 19

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Paragraph 20

-Article 9

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 28

-URI http://asc.fasb.org/extlink&oid=6943989&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Net Income

-URI http://asc.fasb.org/extlink&oid=6518256

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Other Comprehensive Income

-URI http://asc.fasb.org/extlink&oid=6519514

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257